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Background: Norway has the highest rates of hip fractures worldwide. Hip fracture patients 
represent a vulnerable group with high mortality and morbidity after one year, and as the 
elderly population is increasing a consecutive increase in hip fractures is expected. Energy 
and protein requirements are increased during disease and inflammatory state, and muscle 
wasting can be expected in bedridden patients. The poor nutritional status in hip fracture 
patients is increasingly recognized, however, little is known about food intake and weight 
changes in the immediate postoperative period in Norwegian patients. 
 
Objective: To investigate energy and protein intake and weight development during the acute 
and rehabilitation phase after a hip fracture in Norwegian patients, and to consider the patients 
nutritional risk.  
 
Methods: Forty patients were recruited to the study during hospitalization for hip fracture, 
and were investigated at hospital (median 3 days after surgery), at a rehabilitation unit 
(median 15 days after surgery) and at home (median 63 days after surgery). Energy and 
protein intake, weight, mid-upper arm circumference and triceps skinfold were collected at all 
visits. Nutritional risk screening, new mobility score, bioelectrical impedance analysis, 
handgrip and quadriceps strength were carried out at the rehabilitation unit/ at the home of the 
patients.  
 
Results: We found a very low energy and protein intake at hospital where no patients reached 
their estimated requirements, and an improved, but still insufficient energy and protein intake 
at rehabilitation and at home. Eleven out of 14 patients lost weight from hospital to 
rehabilitation (median for the group was -2.9 kg, p = 0.048) and eight out of 12 patients lost 
weight from hospital to home (median for the groups was -2.2 kg, p = 0.147). Eighty percent 
of the patients were in nutritional risk at the rehabilitation stay. Due to the small number of 
patients and the high drop-out rate, most findings did not achieve statistical significance, and 
therefore the results have to be interpreted with care. 
 
Conclusion: In conclusion, energy and protein intake was very low in hospitalised hip 
fracture patients, and remained sub-optimal during rehabilitation and after returning home. A 
significant weight loss and a high number of patients in nutritional risk, suggest that the 




Energy requirement - the energy intake needed to recover energy expenditure in individuals 
with body weight, body composition and physical activity compatible with good health [1]. 
Hip fracture - a fracture in the upper quarter of the femur (thigh) bone [2]. 
Low energy fracture - a fracture resulting from a same-level fall [3]. 
Malnutrition - a cellular imbalance between the supply of nutrients and energy and the body´s 
demand for them ensure growth, maintenance, and specific functions [4]. 
Nutritional risk - a state where at least one of the following is present: a BMI <20.5 kg/ m2, 
weight loss the last weeks, a reduced food intake the last weeks, or any serious disease [5, 6]. 
Nutritional status - the extent to which nutrients are available to meet metabolic needs [7]. 
Osteoporosis - a systemic skeletal disease characterized by low bone mass (a T-score of - 2 
standard deviations) and deterioration of bone tissue, with a consequent increase in bone 
fragility and susceptibility to fracture [8]. 
Protein requirement - the lowest level of dietary protein intake that will balance the losses of 
nitrogen from the body, and thus maintain the body protein mass, in persons at energy balance 
with modes levels of physical activity [9]. 
Sarcopenia - the loss of skeletal muscle mass and muscle function measured by muscle 
strength or physical performance [10]. 
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List of abbreviations 
25(OH)D  - 25-hydroxyvitaminD  
BIA - bioelectrical impedance analysis 
BMD - bone mineral density 
BMI - body mass index 
BW - body weight 
CRP - C-reactive protein 
E %: Energy percent; amount of nutrient as percentage of total energy intake. 
ESPEN - the European Society for Clinical Nutrition and Metabolism  
FFM - Fat free mass 
FM - fat mass 
LOS - Length of stay (at hospital) 
MUAC - Mid upper arm circumference 
N-balance - Nitrogen balance 
NNR - Nordic Nutrition Recommendations  
NMS - New mobility score 
NRS 2002 - Nutrition Risk Score (2002)  
PA - Phase Angle 
REE - resting energy expenditure 
SD - standard deviation  
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1 Introduction 
1.1 Importance and prevalence of study topic 
The world’s population is steadily increasing, and the elderly are the fastest growing group in 
the world, also in Norway [3, 11]. In 2010, 13 % of the population in Norway was 67 years or 
older, in 2060 the elderly are expected to be 22% of the total population [11]. With the elderly 
contributing to over 1/5 of the population, new medical challenges arise [12]. Scandinavia, 
with Norway ranging on the top, has the highest rates of hip fractures worldwide [3, 13]. 
Every year there are about 9,000 hip fractures in Norway and this number is expected to 
increase in the future due to an increase in the elderly population [14]. It is estimated that one 
in six white women will have a hip fracture in their lifetime [15] and about 70 % of the 
fractures in Norway are found in women [16].  
 
A hip fracture is a fracture in the upper quarter of the femur bone. It can occur from a fall or 
from a direct blow to the side of the hip. There are three different types/ zones of hip fracture; 
intracapsular fracture, intertrochanteric fracture and subtrochanteric fracture, and a hip 
fracture can consist of a fracture in one or more of these zones (Figure 1) [2]. 
 
 
Figure 1. Types of hip fractures. 
a) intracapsular fracture: This fracture occurs at the level of the “neck” of the bone and may have loss of blood 
supply to the bone, b) intertrochanteric fracture: This fracture occurs further down the bone and tends to have 
better blood supply to the fracture pieces, c) Subtrochanteric fracture: This occurs even further down the bone 
and may be broken into several pieces. Picture and information from the American Academy of Orthopaedic 
Surgeons [2]. 
 
Elderly hip fracture patients are a vulnerable group. Hip fractures are associated with high 
mortality rates and prolonged disability, and require long-term medical care. This type of 
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fracture causes more economic costs, it leads to more disability, and it is associated with 
higher mortality than other fractures [3]. Hip fracture patients in general have poorer 
nutritional status than their healthy peers, and the risk of institutionalising is great [17]. Thus, 
even minor improvements in the treatment of these fractures are of great importance.  
1.2 Outcome and prognosis after a hip fracture 
For elderly patients, hip fractures lead to a 2-3 fold increased mortality than expected for age 
within the first year after fracture [15, 18]. This number corresponds to a mortality rate of 20-
30 % during the first year after fracture, which gives similar or even higher mortality rates 
than pancreatic or stomach cancer [18-22]. Most deaths occur the first 3 - 6 months after 
fracture, and excess mortality decreases thereafter, but is still higher than in the general 
population. Deaths are in part related to comorbidity and in part due directly or indirectly to 
the hip fracture event itself (about 25 % of the deaths). The mortality is found to be higher in 
men than in women, also after accounting for the higher mortality rates for men in the general 
population [18]. 
 
After a hip fracture autonomy is reduced. The risk of institutionalisation after such a fracture 
is high; about 50 % of patients with a good functional status before a hip fracture are unable 
to regain their independent lifestyle after a hip fracture [3, 19]. A Norwegian study that 
investigated hip fracture patients, found that of those who used to be healthy community-
dwelling citizens before fracture, one fifth moved to a nursing home, half of the patients used 
walking aid and half of them needed assistance in their own homes one year after the fracture 
[22]. Studies often exclude patients with several comorbidities and mental impairment, and it 
can be assumed that the real hip fracture population is in worse condition than what is 
captured by investigation [17, 23-27]. This is of importance as it is estimated that 40 % of hip 
fracture patients are mentally impaired [28]. 
1.3 Risk factors for hip fracture and osteoporosis 
1.3.1 Bone mineral density 
Risk factors for osteoporosis are inevitably also risk factors for hip fracture, due to the strong 
association between hip fracture and bone mineral density (BMD). As BMD peaks in early 
adulthood and deteriorate during aging, the risk of suffering from a hip fracture increases 
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exponentially with age [3, 29]. Individuals cannot feel bone deterioration, and therefore a 
fracture is often the first sign of low bone mass in patients. This fracture is therefore the 
international barometer for osteoporosis [3]. About 90 % of hip fractures in both sexes results 
from a simple fall from standing height or less, these are called low energy hip fractures and 
are the type of fracture associated with osteoporosis [3]. The risk ratio for hip fracture in men 
and women increases with about 2.9 for each standard deviation (SD) decrease in BMD [8]. 
As postmenopausal women have a more drastic decrease in BMD than men at the same age 
and because women generally live longer than men, the majority of low energy hip fractures 
occur in women [3].  
 
A Norwegian prospective study investigated risk factors for hip fracture among a 
representative population of middle aged adults, and found several age-adjusted relative risks 
for hip fracture: They found that two thirds of the fractures occured in women. Also, a body 
mass index (BMI) <22 increased risk for hip fracture, self-reported low physical activity at 
work also showed increased risk. Heavy smoking (>15 cigarettes daily) also increased the risk 
for hip fracture. These variables are all related to BMD and bone loss [29]. Several diseases 
will also negatively affect BMD, as chronically obstructive pulmonary disease [30], HIV [31] 
and cancer types [32]. 
1.3.2 Dietary risk factors 
Several dietary factors have been identified as important for maintaining bone health and 
reducing the risk of osteoporotic fractures [33]. Of relevance to this study dietary protein and 
dietary protein in association with calcium intake will be presented in more detail, although 
calcium per se [34], vitamin D [35], alcohol intake [36] and consumption of n-3 fatty acids 
[37] also influences BMD by different mechanisms.  
 
The role of dietary protein on bone health has been controversial. At high-protein intakes, 
urinary calcium loss increases, but at the same time protein increases calcium absorption and 
bioavailability. These seemingly opposite effects makes it uncertain what the net effect of 
high protein diets is on calcium economy and bone health [38]. Any negative effect of protein 
might be opposed by an increase in the protein-sensitive anabolic mediator insulin-like 
growth factor, IGF-1 and enhancement of lean body mass with protein intake [39]. European 
Food Safety Authority regarded the proof level of the association between bone health and 
protein intake as inconclusive [40]. Nevertheless, there seems to be an interaction between 
4 
protein intake and the intake level of calcium. Several studies suggest that dietary protein 
works synergistically with calcium to improve calcium retention and bone metabolism [41].  
1.3.3 Non-skeletal clinical risk factors 
The pathogenesis of hip fractures is multifactorial, and low BMD alone cannot completely 
account for their occurrence [42]. Risk factors who are independent of BMD are called non-
skeletal clinical risk factors, and they contribute significantly to fracture risk over and above 
that provided from BMD [43]. Maternal hip fracture is positively associated with hip 
fractures, even after adjusting for BMD. Tachycardia at rest and previous hypothyroidism is 
also associated with hip fracture [3, 44]. Impairment with the eyes like poor vision, poor 
depth perception and poor contrast sensitivity are all associated with hip fracture [43, 44]. Use 
of systemic corticosteroids, rheumatoid arthritis and neuromuscular disorders are also risk 
factors of hip fracture independent of BMD [45]. 
1.3.4 Sarcopenia 
Aging is associated with an increase of fat mass (FM) during adult life and a decrease in fat 
free mass (FFM) from about 40 years of age, and can result in the age-related disease 
sarcopenia [46]. Aging per se does not cause sarcopenia, rather mechanisms caused by 
inactivity and a diet with low energy and protein intake. Sarcopenia is characterized by a 
decreased response and/ or sensitivity of otherwise adequate amounts of protein and leads to a 
higher threshold value for protein synthesis than for others [47, 48]. As it requires larger 
protein amounts to reach the threshold for protein synthesis at each meal, further protein 
breakdown can be expected [49]. Sarcopenia affects about 10 % of elderly 60-70 y, and up to 
50 % of elderly over 80 y [48]. Low levels of muscle mass and poor muscle strength increase 
the risk of falls and fracture [50]. 
1.4 Energy requirement for the elderly with disease 
The principle behind the energy requirement is to recover energy expenditure to achieve 
energy balance, the physiological state where daily energy intake equals energy expenditure 
over time, and both body weight and body composition are constant. Thus, to estimate energy 
requirement, energy expenditure must be estimated. The daily energy expenditure can be 
divided into three components; resting energy expenditure (REE), diet-induced thermogenesis 
and energy expenditure caused by physical activity [1]. REE depends largely upon FFM, 
which requires more energy than FM. As FFM tends to decline with age, REE is usually 
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lower in the elderly than the younger adults [12]. Also, physical activity tends to decline with 
age. Diet-induced thermogenesis is found to be the same regardless of age [1]. Altogether, 
total energy expenditure is usually lower for the older than the younger persons [12]. There 
exist prediction equations for estimation of energy expenditure, which can be used as rough 
estimates when other assessment methods are unavailable [5, 51]. 
 
Surgical stress will however lead to an increased energy expenditure [52]. This is because the 
inflammatory reaction will lead to production of catabolic cytokines, which increases energy 
expenditure. A study performed by Paillaud et al. found that hip fracture patients remained in 
an increased metabolic state throughout their study which lasted two months, and found a 
significant difference in energy expenditure between healthy elderly and elderly with 
inflammation [52]. These findings are concordant with results of other studies showing 
significant effects of trauma and surgery on resting energy expenditure [52-54].  
1.5 Protein requirement in the elderly  
Protein requirement is met when the supply of nitrogen (via proteins) from the diet 
corresponds to the body´s loss, a situation of nitrogen balance (N-balance). Measuring the N-
balance has been the main procedure for calculating energy requirements the last century [1, 
9]. Pedersen & Cederholm have written a systematic review regarding protein requirements in 
healthy elderly subjects. They found the evidence as probable that the estimated average 
requirement of 0.66 g good-quality protein/kg bodyweight (BW) per day and the subsequent 
recommended daily allowance (RDA) of 0.83 g good-quality protein/kg BW per day is 
satisfactory for all adult age groups, including the elderly, based on N-balance studies [55]. 
However, the authors emphasise that this is the minimum dietary protein need, which 
corresponds to an average intake of approximately 10 E% from protein. The estimation of an 
optimal level of protein intake in the elderly however, can be higher for several reasons, like 
sarcopenia and osteoporosis being processes that are too slow to de discovered in short-term 
N-balance studies. Also, low-protein diets can induce adaptions to spare nitrogen, making it 
hard to determine the level of optimal protein intake rather than what is needed to avoid 
deficiency [56].  
 
The Nordic nutrition recommendations (NNR) also emphasize that any protein catabolism 
and loss due to disease and bed rest (see 1.7) must be replaced from the diet and thus 
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represent an added need for dietary protein [1]. For these reasons, several organisations have 
increased the protein requirements for the elderly [1, 49, 56]. Pedersen & Cederholm and 
NNR recommended that an intake up to at least 1.2-1.5 g protein/ kg BW/day (according to 
15-20 E%) is safe and may have beneficial effect for the elderly population, versus the 
recommended dietary allowance of 0.8-1.0 g protein/ kg BW/ d that is recommended for the 
younger adults [1, 55]. The European Society for Clinical Nutrition and Metabolism (ESPEN) 
recommends a recommended dietary allowance of 1.0 - 1.2 g protein/kg BW /d for healthy 
older adults, and 1.2 - 1.5 g protein/kg BW /d for older adults who have acute or chronic 
illnesses, with even higher intake for individuals with severe illness or injury [49].  
1.6 Energy and protein intake in hip fracture patients 
A British study found that hip fracture patients had worse nutritional status at admission to 
hospital than what was fond in a healthy age-matched community-dwelling group by 
comparison of anthropometric measures. Further they discovered that a poor nutritional status 
before the fracture also contributes to a further deterioration in nutritional status that will 
affect clinical outcome [17]. A Swedish study found that hip fracture patients had a 
suboptimal energy intakes during hospital stay but did not investigate the group further [23]. 
Poor nutritional status is one of the strongest predictors of a poor outcome after hip fracture, 
reported associations between malnutrition and hip fracture are excess mortality, worse 
mobility and functional outcomes, poorer cognition, function, higher rates of comorbidity and 
rehospitalisation [39]. Several studies have investigated the energy intake thoroughly at 
hospital, but few studies consider the rehabilitation phase thoroughly [17, 23, 57]. For follow-
up studies, mortality is often the main outcome investigated [20, 27]. 
1.7 Nutritional risk and weight loss in elderly hip fracture patients 
Nutritional risk screening (NRS 2002) is a validated tool to assess information about 
nutritional risk [5]. Nutritional risk is identified by pronounced unintentional weight loss, 
chronically low BMI, a reduced dietary intake or severe illness. Patients who have one or 
more of these conditions requires urgent intervention [58].  
 
A BMI <20.5 kg/ m2 is used to identify hospitalised patients at nutritional risk [58, 59]. A low 
BMI is related to mortality in the elderly population, while no excess mortality is found in 
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overweight elderly individuals versus normal-weight elderly [60, 61]. Following a study of 
elderly nursing home residents in Istanbul, the authors suggested that better functional status 
was associated with higher BMI values even in BMIs >30 kg/ m2 [62]. A possible reason for 
this is that a low BMI in the elderly is associated with low muscle mass, not necessarily low 
fat mass. FFM, in particular muscle and bone, is positively associated with strength, physical 
function and overall quality of life, while a low FFM is associated with adverse outcomes as 
presented for sarcopenia [50]. These findings can also possibly be explained by the decrease 
in height expected with aging which will lead to an increase in BMI without a gain in body 
mass [62].  
 
Involuntary weight loss in the elderly is associated with undesirable health outcomes like 
decreased functional status, institutionalization and increased mortality. Weight loss is both a 
marker of, and an independent contributor to, these adverse health outcomes [63]. A widely 
used definition for clinically important weight loss is 5 % or more over 6-12 months [59], 
although a weight loss of 3 % of body weight also was associated with adverse health 
outcomes in frail elderly [64, 65]. A study in Caucasian female hip fracture patients found 
that weight loss is associated with weakness during hip fracture recovery [59].  
 
It is found that patients who are bedridden for several days will experience a loss of muscle 
mass, mainly due to a decrease in muscle protein synthesis [66]. Also, healthy elderly 
participants in an intervention study (mean 67 y) experienced a greater muscle mass loss in 
ten days (= 1 kg muscle from the lower extremities) than younger participants [67]. This 
decreased muscle mass due to bed rest in older subjects is associated with large reductions in 
strength. The hypermetabolic state during illness and disease mentioned earlier may also 
result in alteration in body composition, with severe muscle wasting [66]. 
 
Compared to younger adults, older adults usually eat less, including less protein. Due to the 
higher needs for the diseased, sarcopenic and bedridden elderly, this leads to an imbalance 
between protein supply and protein requirement, and represent a challenge in the elderly [49]. 
Loss of muscle mass is associated with mobility disorders, increased risk of falls, reduced 
ability to function in activities of daily living, loss of independence and reduced life 
expectancy [50]. 
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1.8 Current health measurements 
1.8.1 Anthropometric measures  
A quite direct marker of nutritional status are anthropometric indices, such as weight in 
relation to height (BMI), triceps skinfold for body fat, and mid upper arm circumference for 
muscle mass and fat mass [68]. Classification of underweight, normal weight, overweight and 
obesity is obtained by using BMI, and it is calculated by dividing weight in kilograms with 
square height in metres (kg/m2) [69]. A BMI under 20.5 kg/m2 is categorized as underweight 
for the elderly [58]. BMI alone may not be sufficient to establish risk of adverse outcomes, as 
it does not take into account the distribution between different tissues [62]. Also, weight and 
height data may be unrealistic to perform at sick geriatric patients [70].  
 
Significant changes in body composition occur with aging, which cannot be discovered by 
BMI [71]. Bioelectrical impedance analysis (BIA) is a non-invasive, inexpensive and portable 
method that can been used for body-composition [72]. The BIA measures body resistance and 
reactance, and by a suiting formula FM and FFM can be obtained. However, obtaining FM 
and FFM from BIA relies on the assumption that hydration level is constant. This is often not 
the case for elderly, especially not when ill [73].  
 
To avoid any oedema, dehydration or other disturbances in hydration level, mid-upper arm 
circumference (MUAC) can be used to assess information about body composition. A study 
found that MUAC has a better association with mortality than BMI in older men and women 
[74]. Another study found that decreases in MUAC had the strongest association of mortality 
among eight anthropometric measures [75].  
1.8.2 Phase Angle 
Phase angle (PA), a value calculated directly from BIA measurement as the arc tangent of the 
ratio of resistance and reactance, has been shown to be predictive for prognosis and mortality 
in different diseases and in geriatric patients [76]. PA relates to the distribution of intra- and 
extracellular fluid and also with the cell membrane integrity, and is normally calculated 
automatically on the BIA device [77]. Men usually have a wider PA than women, younger 
individuals has wider PA than older, and also PA is inversely related to BMI [72]. A narrow 
PA is associated with frailty and mortality in geriatric patients and healthy elderly women and 
men. It is therefore suggested that PA can be interpreted as a global marker of health and a 
predictor of poor outcome in the elderly [70, 72, 77]. PA has also been shown to decrease 
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with increased nutritional risk, and indicates a loss of cell mass in malnutrition. Studies 
suggest that a low PA is associated with low body weight and poor outcome [76]. There are 
no uniform consensus regarding reference values, however, 6.2° and 5.6° are commonly used 
for men and women, respectively [72]. Kyle et al defined low PA as <5.0° in men and <4.6° 
in women [78]. 
1.8.3 Strength 
Older adults with reduced muscle strength have higher mortality [79]. Handgrip dynamometer 
is an easy and non-invasive tool to measure handgrip strength. There is an agreement that 
handgrip strength can characterise overall strength [80]. The strength of handgrip can also be 
used as a health screening tool due to its relationship to physical activity, nutritional status, 
future disability and mortality [79-81]. Knee extension exercise, which measures strength in 
quadriceps muscle, is also a strong and independent predictor of mortality in older adults [79]. 
Both strength measurements mentioned is associated with mortality also when adjusted for 
muscle mass, hence the association cannot be contributed to sarcopenia [79].  
1.8.4 Biochemical markers 
It is normal to use biochemical markers for assessing nutritional information in individuals, 
but these methods are hampered by their response to acute illness and injury. Inflammation 
follows surgery and leads to several changes in the body that replaces the normal homeostatic 
mechanisms, e.g. the production of acute phase proteins and the decrease in micronutrient 
concentration in plasma [82]. This makes it important to follow the evolution of a systemic 
inflammatory response in nutrient assessment situations for sick patients; this can be 
conducted by measuring the acute phase protein C-reactive protein (CRP) which can increase 
a thousand-fold during an inflammatory response, and is easy to measure [82, 83]. 
 
Serum albumin is an established biochemical marker of nutritional status [26]. As albumin is 
a negative acute phase protein, the rate of albumin synthesis is affected by both nutrition and 
inflammation [84]. Also 25-hydroxyvitaminD (25(OH)D), the component that is normally 
collected to assess vitamin D status, is affected by inflammation. A rapid significant decrease 
in plasma concentrations of 25(OH)D is found during the evolution of an inflammatory 
response, and it also stayed low for three months [85]. Routine biochemical assessment in the 
hospital includes also measurement of haemoglobin and serum creatinine. Haemoglobin is 
usually measured to monitor any risk of huge blood losses, and from a nutritional point of 
view, it can reflect iron status and indicate iron-deficient anemia, although the sensitivity and 
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specificity are limited [86]. Serum creatinine reflects bot the renal function and the muscle 
mass, as it is excreted by the kidneys and formed at a constant rate in the skeletal muscles 
[87].  
1.8.5 Length of stay at hospital  
Length of stay (LOS) at hospital thoroughly associated with nutritional status [57, 88]. LOS is 
an easily measurable outcome parameter, and beside nutritional status the variable could be an 
integration of the severity of illness and patients health status in general - and is affected by 
the severity of trauma and disease, overall medical or surgical treatment, quality of care, 
resources available and the environmental conditions outside the hospital [88].  
1.8.6 New Mobility score 
Towards the end of the 20th century, Parker & Palmer validated the new mobility score 
(NMS), which at a high significant prediction can forecast mortality in hip fracture patients at 
one year [89]. The NMS is also associated to the regain of independence in basic mobility 
after surgery [90]. To our knowledge, new mobility score has not previously been associated 
with nutritional status.  
1.9 Aim and hypothesis of the research project 
The poor nutritional status in hip fracture patients is increasingly recognized, however, little is 
known about food intake and weight changes in the immediate postoperative period in 
Norwegian patients. Up until now, most investigations have been performed by identifying 
outcomes one year after the fracture, without paying specific attendance to the early post-
fracture period, or are conducted in different settings where procedures for hospitalisation and 
rehabilitation are different from Norway [22, 25, 52]. Hip fracture patients represent a 
vulnerable group with adverse outcomes after one year, yet more acute outcomes are 
unknown.  
 
We hypothesize that old hip fracture patients will have a sub-optimal energy and protein 
intake during the acute and rehabilitation phase after the fracture, and this will be associated 




2 Methods  
2.1 Study Design 
To investigate the acute and rehabilitation phase for elderly hip fracture patients, a 
longitudinal study from surgery to the end of the rehabilitation stay was conducted. Data were 
collected from patients at the hospital shortly after surgery, during rehabilitation at a nursing 
home (which is a common procedure for most hip fracture patients in Norway), and when the 
patients returned home (Figure 2). The study was a descriptive, observational study, and it 
was conducted from August 2014 to February 2015. The Research Ethics Committee of 
Western Norway approved all procedures involving humans. Participants in the current study 
were also requested to join a larger randomised control study, Fish Intervention Studies. 
 
 
Figure 2. Study timeline. 
Hospital visit was median 3 days after surgery, rehabilitation visit was median 15 days after surgery while home 
visit was median 63 days after surgery. Interquartile ranges are presented in parenthesis.  
* Nutritional risk screening (NRS) and new mobility score (NMS) was conducted at second visit. If 
rehabilitation visit was not conducted, these measurements were conducted at home.  
2.2 Study Population 
A total of 40 patients, 14 men and 26 women, were recruited by a researcher in two hospitals 
in Bergen. The hospitals monitored were Haukeland University Hospital and Haraldsplass 
Deacon Hospital. The patients were over 60 years old, and had to be hospitalized for their first 
hip fracture. The patients included were in normal cognitive function; nurses working at the 
current departments excluded persons with signs of cognitive impairment /dementia. Two 











walking aid pre-fracture were also excluded. A complete list of the inclusion -and exclusion 
criteria’s is found in Table 1.  
 
To recruit patients, a researcher visited the relevant departments in Haraldsplass Deacon 
Hospital and Haukeland University Hospital on workdays to check whether new patients, 
suitable for the project, had arrived. The researcher recruited willing patients. The patients 
were informed about the study design orally and written, and signed the consent forms 
(appendix 1). Rehabilitation facilities was informed, and consented to this cooperation.  
 
Table 1. Inclusion criterias for the study patients 
 
2.3 Energy intake and requirement  
To assess the food consumption of patients at all visits, 24 h recalls were conducted, all by the 
same person. The 24 h recall was carried out in that the interviewer asked the patients to recall 
the exact food intake during the preceding day and night. To collect the 24 h recall, the 
interview guide from Gibson was used  (appendix 2) [91]. Energy and macronutrient intake 
were estimated by use of Kostholdsplanleggeren (the diet planner) [92]. The nutritional 
content in Kostholdsplanleggeren are based on data from the Norwegian food composition 
table [93]. 
 
Numbers for estimating energy requirements were found in Haukeland university hospitals 
guidelines for good nutritional practise (appendix 3) [94], which is based on the Norwegian 
national professional guidelines for prevention and treatment of malnutrition [51]. We 
Inclusion Criterias
> 60 years
Recent first Hip Fracture
Normal cognitive function
Community dwelling           
pre-fracture
Must live near Bergen
No walking aids pre fracture
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estimated protein requirement as proposed by ESPEN [49]. During hospital stay, we used the 
mean value of the protein recommendations for elderly with disease, 1.35 g protein/ kg BW/ 
d, to calculate each patient’s protein requirement. For rehabilitation and home visits, we used 
the mean value of the protein recommendations for the healthy elderly, 1.1 g protein/ kg BW / 
d, to calculate each patients protein requirement [49]. 
2.4 Nutritional risk screening 
To detect patients at risk of malnutrition, the first four questions of the Nutritional Risk 
Screening (NRS 2002) was used [58] as in the study by Tangvik et al. [6] (appendix 4). As 
suggested by Tangvik et al., answering yes to at least one question placed the patients in 
nutritional risk [6]. The four questions were: 
Is BMI < 20.5 kg/m2? 
Has the patient lost weight within the last weeks? 
Has the patient had a reduced dietary intake in the last weeks? 
Is the patient severely ill?  
2.5 Weight and anthropometry 
To conduct the weight of the patients, a SECA chair scale, model 952 was used during 
hospital stay. If the patients were unable to leave the bed, self reported weight was collected. 
During the two following visits, an electronic scale SECA flat scale, model 877 was used. 
During hospital stay the patients were wearing light hospital clothes, while at rehabilitation 
stay and home clothing was heavier. This was taken to account by withdrawing 1 kg from 
gross weight. The two different weights used in the study had a systematic disparity of 0.2 kg, 
and was considered unimportant. Height was measured at home visit with Seca stadiometer, 
model 217 to the closest 0.5 cm. If patients did not attend this visit, self-reported height was 
used. Body weight and BMI were estimated to the closest 0.1 kg and kg/m2 respectively.  
 
MUAC was measured with Seca measuring tape, model 201. The triceps skinfold 
measurement used, was a precision thickness caliper from Lange skinfold caliper (Beta 
technology). Bedridden patients were not asked to rise from the bed, although patients should 




Body Composition was acquired by using the BIA 101 Anniversary Sport edition (AKERN). 
It measures body resistance and reactance, and by the use of the formula of Kyle [95], as 
suggested by Genton [96], the amount of FFM in kg was calculated. Patients who did not 
have a pacemaker attended the measurement. Further, the manufacturers guidelines were 
followed. Phase angle was directly calculated from the BIA measurement.  
2.6 Handgrip and Quadriceps strength  
Handgrip strength was measured at the home visit with the JAMAR hydraulic hand 
dynamometer (Sammons Preston). Quadriceps strength was measured at the home visit on the 
leg with no fracture, with knee extension apparatus Chatillon force measurement, the DFE-II 
series (AMETEK). Both tests were carried out three times and the mean value, estimated to 
the closest 0.5 kg, was recorded. Otherwise, the manufacturer`s guidelines were followed. 
2.7 New Mobility Score 
Functional level after returning home was evaluated with the NMS. The NMS is a composite 
score of the patient’s ability to perform indoor walking, outdoor walking, and shopping after 
the hip fracture, providing a score between 0 and 3 (0 = not at all, 1 = with help from another 
person, 2 = with an aid, and 3 = no difficulty and no aid) for each function, resulting in a total 
score ranging from 0 (no walking ability at all) to 9 (fully independent) (appendix 4) [89].  
2.8 Blood Samples and remaining values 
Blood values for albumin, hemoglobin, 25(OH)D, CRP and creatinine were collected from 
patient journal from mainly one-day pre surgery. Remaining values, such as length of stay at 
hospital and other information like the presence of osteoporosis, type of hip fracture and type 
of fall, were also collected from the patient journal. 
2.9 Statistical analysis  
The data was analysed in IBM SPSS Statistics 22 [97]. The Shapiro-Wilks test was used to 
assess normality. As most of the data were not normally distributed, and the number of 
participants was relatively small, we used non-parametric tests on our data. Results are 
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presented as medians with interquartile ranges (Tukeys Hinges), and minimum and maximum 
score. Baseline characteristics were also presented as means and standard deviations. The 
Wilcoxon Signed Rank test was used to evaluate if changes inside a group was statistically 
significant between hospital and rehabilitation, and hospital and home. The Kruskall-Wallis 
test was used to evaluate if differences between groups were statistically significant, e.g. 
between groups with and without nutritional risk. Spearman’s rho was used to detect any 
statistical significant correlation between two variables. Any changes in groups or differences 
between groups were considered statistically significant if p < 0.05. 
 
Due to substantial amounts of missing data, patients who only completed the first visit were 
excluded from analysis, except at the baseline characteristics (Figure 3). For the presentation 
of nutritional and weight status (Table 4 & 5), all patients who completed more than one visit 
were included. Visit at hospital was compared with rehabilitation visit. Visit at hospital was 
also compared with home visit. Figure 3 shows how the current dataset led to 16 patients for 
comparing hospital and rehabilitation stay, and 15 patients for comparing hospital and home 
stay. Complete case analysis was performed to see individual data of those who conducted all 
visits. 
 
Some post-hoc power testing were performed to calculate how many patients would be 
required to achieve statistical significant results regarding changes in  % weight and BMI. We 




Figure 3. The current dataset and the distribution of patients among the visits.  
* 18 patients only participated in the first visit, and this data is only used for baseline characteristics. 
Seven patients attended visit at hospital and rehabilitation. Nine patients attended all visits. Six patients attended 
visit at hospital and home.  
16 patients could therefore be compared between hospital and rehabilitation, and 15 patients could be compared 










3.1 Flow of subjects 
Forty patients, 26 of them women (65 %) were included in the study after surgery during 
hospital stay for hip fracture (Figure 4). Eighteen patients withdrew from the study after the 
first visit. Sixteen patients conducted the second visit at rehabilitation, and fifteen patients 
conducted the last visit, at home. The patients who only participated in one visit, dropouts, 
(n=18) were withdrawn from the analysis, except for the baseline characteristics (Table 2).  
 
Figure 4. Flowchart of study subjects. 
* Six patients did not undergo the second visit (at rehabilitation), but conducted the third visit. Twenty-two 
patients conducted thereby more than one visit.   
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3.2 Baseline Characteristics 
The median age of the 40 patients who were included at baseline was 81 years, 78 years for 
the men, and 81 years for the women (Table 2). Blood values, mainly from a sample drawn 
one day before surgery were available for albumin, hemoglobin, vitamin D status (25(OH)D), 
CRP and creatinine, and are also presented for all patients in Table 2.  
 
Almost 70 % (n = 27) of the patients fractured the hip from standing height or less in their 
homes (low-energy hip fracture), four patients fell down the stairs, two patients were in a 
bicycle-accident, two patients fell during syncope and five patients fell outside. The highest 
fraction of types of fracture was intra-capsular (60 % of the fractures, n = 23). There was only 
one sub trochanteric fracture, and the rest (n = 14) were inter-trochanteric fractures. Seven of 
the forty patients were diagnosed with osteoporosis. Seventeen of the patients did not have 
osteoporosis, while for 14 patients the diagnoses were not available. 
 
There were no significant differences in LOS for those who only conducted visit A (drop-
outs) and those who conducted more than one visit (p = 0.419). The dropouts were apparently 
older (81 years vs. 75 years), and had a lower energy intake at hospital (1070 kcal versus 
1670 kcal), but none of these findings were statistically significant, p = 0.195 and p =0.205 
respectively. 
 
Baseline characteristics for the patients who conducted more than one visit are presented in 
Table 3. The median BMI was 22.8 kg/m2 and 23.1 kg/m2 for men and women, respectively. 
The median energy intake at hospital was 1710 kcal for men and 1060 kcal for women. The 
median LOS at hospital for those who conducted more than one visit was 6 days, and there 
was a significant positive association between LOS and age (r = 0.618, p =0.008) (All 
correlation information are found in appendix 5). No nutritional or weight related variables 
had any correlation with LOS (energy intake at hospital, weight/BMI at hospital, nutritional 
risk or weight loss during study period).   
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Table 2. Baseline characteristics of all the 40 hip fracture patients recruited at hospital 
 
LOS = Length of stay (at hospital). 
25(OH)D  - 25-hydroxyvitaminD  
CRP = C-reactive protein.  
* Number of days before surgery the blood samples was collected. 
Results are presented as means with Standard Deviation (SD), medians with interquartile ranges (IQR) and minimum and maximum values. 
Reference values for blood samples are presented for men and women. 
Number of blood samples varies as not all samples was analysed at hospital.   
n  Mean (SD)
Median 
(IQR) Min / max n Mean (SD)
Median 
(IQR) Min / max
Reference 
value n Mean (SD)
Median 
(IQR) Min / max
Reference 
value
n 40 14 26
Age 39
77.6           
(9.4)
81.0                    
(70.5-83.5) 59 / 95 13
75.5          
(10.2)
78.0                
(67.0-82.0) 61 / 95 26
78.6          
(9.1)
81.0                 
(73.0-86.0) 59 / 93
LOS 38 6.5          
(2.5)
6.0                   
(5.0-7.0)
3 / 14 13 6.7           
(3.2)
5.0                
(4.0-9.0)
4 / 14 26 6.3               
(2.0)






38 0.95        
(0.6)
1                  
(1-1)
0 / 2 13 0.7         
(0.5)
1                  
(0-1)
1 / 1 26 1.08         
(0.6)
1                  
(1-1)
0 / 2
Albumin, g/l 33 41.6           
(2.7)
42.0                  
(40.0-44.0)
37 / 49 12 40.4           
(2.1)
42.0            
(40.5-44.0)
37 / 44 39 - 48 21 41.8          
(3.0)
41.0              
(40.0-44.0)
37 / 49 36 - 48
Haemoglobin, 
g/dl 38
13.3           
(1.9)
13.5                 
(12.4-14.6) 9.10 / 16.3 13
13.5           
(2.3)
14.6            
(12.3-15.5) 9.1 / 15.6 13.4 - 17.0 25
13.2          
(1.7)
13.5             
(12.5-14.0) 9.7 / 16.3 11.7 - 15.3
25(OH)D, 
nmol/ l 23
72.3           
(27.5)
67.0                 
(58.5-88.5) 18.0 / 130.0 8
59.9          
(24.9)
63.5               
(44.5-76.5) 18.0 / 92.0 50 - 113 15
78.9        
(27.3)
70.0          
(60.0-101.0) 36.0 /130.0 50 - 113 
CRP, mg/ l 38 12.2           
(29.7)
2.0                    
(1.0 - 6.0)
<1 / 159 13 15.5 (43.3) 2.0                   
(1.0-4.0)
<1 / 159 < 5 25 10.5        
(20.3)
2.0               
(1.0-6.0)
<1 / 80 < 5
Creatinine, 
µmol/ l
38 76.3           
(34.0)
68.5                    
(56.0 - 83.0)
47 / 252 13 92.2 (50.5) 79.0                   
(66.0-93.0)
56.0 /252.0 60 - 105 25 68.0        
(17.3)
64.0               
(55.0-75.0)
47.0 / 106.0 45 - 90
WomenMenAll patients
Baseline characteristics from all patients
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Table 3. Baseline characteristics for hip fracture patients who conducted more than one visit 
 
BMI = body mass index, kg/m2. 
LOS = Length of stay (at hospital). 
MUAC = mid upper arm circumference. 
E %: Energy percent; amount of nutrient as percentage of total energy intake. 
Results are presented as means with Standard Deviation (SD), medians with interquartile ranges (IQR) and minimum and maximum values. 
Energy requirements were calculated by assuming 29 kcal/kg/day. For patients > 70 y: estimated energy requirement was reduced with 10 % [51]. 
Due to the severity of the patients, n varies between measurements. Not all patients were able to e.g. rise from the bed.  
n  Mean (SD) Median (IQR) Min / max n Mean (SD) Median (IQR) Min / max n Mean (SD) Median (IQR) Min / max
n 22 6 16
Age, years 22 78.5                   
(10.2)
80                      
(72 - 87)
61 / 95 6 75.7          
(12.8)
77.0            
(62.0 - 82.0)
61 / 95 16 79.5          
(9.2)
82.0            
(72.5 - 87.0) 
62 / 93
Weight, kg 19
65.5                   
(10.9)
62                      
(59.5 - 69.5) 47 / 94 5
71.9          
(10.4)
70.0             
(69.9 - 70.0) 60.7 / 89.0 14
63.2          
(10.5)
60.1           
(58.0 - 68.0) 47 / 94
BMI, kg/m2 17 24.0                   
(3.5)
23.0                      
(22.5 - 24.3)
19.7 / 35.4 4 23.2          
(2.2)
22.8             
(21.8 - 24.6)
20.9 / 26.2 13 24.2        
(3.9)




5.9                   
(1.9)
5.0                       
(5.0 - 7.0) 3 / 11 5
5.8         
(2.2)
5                      
(4 - 7) 4 / 7 12
5.9         
(1.9)
6.0                      
(5 - 7) 3 / 11
MUAC, cm 14
27.8                   
(2.7)
27.3                   
(27.0 - 29.0) 23 / 34 4
27.4                     
(3.0)
28.0                     
(25.0 - 29.3) 23.0 / 29.5 10
28.0                     
(2.8)
27.3                     
(27.0 - 29.0) 24 / 34
Triceps skinfold, mm 14 14.8                   
(4.4)
15.0                   
(14.0 - 16.0)
6.0 / 14.0 4 10.5                     
(3.7)
10.5                     
(8.9 - 13.0)
6.0 / 15.0 10 16.6                     
(3.5)
15.0                     
(14.5 - 16.0)
14 / 24
Energy intake, kcal 17 1240                   
(530)
1200                   
(920 - 1670)
410 / 2040 6 1490                     
(620)
1710                    
(850 - 2000)
630 / 2040 11 1110                   
(440)
1060                      
(920 - 1290)
410 / 1920
Energy intake, % of 
requirement
15 63                   
(21)
61                      
(51 - 74)
27 / 94 5 69                   
(25)
75                   
(53 - 88)
35 / 94 10 59                   
(20)
61                  
(51 - 72)
27 / 93
Protein intake, g 17 53                  
(25)
53                      
(33 - 79)
12 / 86 6 71                   
(25)
85                   
(58 - 87) 
26 / 87 11 44                   
(20)
45                   
(31 - 55)
12 / 79
E % from protein 17
18.4                  
(26)
18                       
(16 - 21) 9 / 27 6
20                   
(4)
18                  
(17 - 23) 16 / 27 11
18                   
(5)
18                   
(15 - 20) 9 / 27
All patients who completed more than one visit Men Women
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Regarding the blood samples, one patient was below the reference value for albumin and one 
patient was below the reference value for creatinine. For hemoglobin and 25(OH)D, nine and 
three patients were below reference value, respectively. Eleven patients had higher CRP than 
the reference value. Patients below reference values for hemoglobin and patients above the 
reference value for CRP were apparently older than patients within reference values, median 
81 years and 77 years for hemoglobin (p = 0.068), and 82 years and 78 years for CRP (p = 
0.171). Other than this, there were no apparent or significant differences between groups 
below and within reference values.  
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3.3 Energy and protein intake 
Energy and protein intake by 24-h recall was collected at the hospital (n = 17), the 
rehabilitation unit (n = 16) and at home (n = 15), and are presented in Table 4. 
 
Table 4. Energy and protein intake during study period as observed by single 24-h recalls 
 
E %: Energy percent; amount of nutrient as percentage of total energy intake. 
* Two sets of data missing due to lack of weight data.  
** One set of data missing due to lack of weight data. 
Data are presented as medians with interquartile ranges and minimum and maximum values. 
At hospital, energy requirements were calculated by assuming 29 kcal/kg/day [51].  
At rehabilitation and home, energy requirements were calculated by assuming 33 kcal/kg/day [51].  
For patients > 70 y: energy requirement was reduced with 10 % [51]. 
Protein requirement were calculated by assuming 1.35 g/kg BW/day at hospital, and 1.1 g/kg BW/day at 
rehabilitation and home [49]. 
p-values are not calculated; patient-groups at the different visits are not the same (nine patients are the same in 
all visits). 
 
Median energy intake during hospital stay was 1720 kcal for men, estimated to cover 74 % of 
energy requirement. For the women, energy intake at hospital was 1060 kcal, estimated to 
cover 61 % of the energy requirement. The protein intake during hospital stay was median 86 
g for men, which was estimated to be 72 % of protein requirement. For women, the protein 
intake at hospital was median 43 g, which was median 47  % of estimated protein 
requirement. None of the patients reached their estimated energy and protein requirements at 
the hospital. The energy percent from protein was within recommendations at hospital. Both 
energy and protein intake at hospital was significantly negatively associated with age. Energy 
and protein intake from hospital was collected at different times vs. the surgery, from one to 




min/ max n Median 
(IQR)
min/ max n Median 
(IQR)
min/ max
Energy intake, kcal 17
1200          
(919-1670) 414 / 2040 16
1630            
(1300-2050) 899 / 2790 15
1550                  
(1180-1810) 824 / 2380
Energy intake, % of 
requirement
15* 61           
(51-74)
27 / 94 15** 92             
(74-124)
51 / 228 15 93                        
(72-115)
46 / 139
Protein intake, g 17 53            
(33-79)
12 / 87 16 60             
(48-82)
32 / 112 15 55                        
(42-71)
21 / 116
E% from protein 17 18             
(16-21)
9 / 27 16 17             
(13-19)
10 / 44 15 14                          
12-17)
4 / 23
Protein intake, % of 
requirement 15*
56             
(35-76) 15 / 94 15**
88             
(79 - 115) 43 / 184 15
89                          
(67-104) 32 / 174 
A: hospital B: rehabilitation C: home
Energy intake for patients who participated in more than one visit
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Median intake during rehabilitation was 1860 kcal for men and 1410 kcal for women. Ten out 
of fifteen patients did not reach their estimated energy requirement in the rehabilitation clinic. 
Protein intake was sub-optimal in rehabilitation clinics, median 59 g for men and 58 g for 
women. Ten out of fifteen patients did not reach their estimated protein requirements, 
although median protein consumption reached median 88 % of estimated requirements. 
Energy and protein intake at rehabilitation was collected at varying times concerning the date 
of surgery, from eight to 46 days (median 15 days).  
 
Median energy intake at home was 1990 kcal for men and 1410 kcal for women. Eight of 
fifteen patients did not meet their estimated energy requirement at home. The protein intake 
was 71 g for men and 52 g for women at home. Ten out of fifteen patients did not meet 
estimated protein requirement at home, although median protein consumption reached 89 % 
of estimated requirements. The time of the home visits also varied widely between patients; 
from 38 to 118 days (median 63 days).  
 
For the men there was a tendency towards correlation between days since surgery visit was 
conducted and energy intake; r = 0.794 (p = 0.059) at hospital and r = 0.500 (p = 0.391) 
during rehabilitation. Other than this, there was not observed any significant or apparent 
correlation between days since surgery and energy intake in any of the visits.  
 
Plots of energy intake for individuals are shown in Figure 5.  
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Figure 5. Energy intake for individuals during hospital, rehabilitation and home (kcal) 
Scattered dot plot showing energy intake at hospital, rehabilitation and home for individuals. 
Black squares show the men, grey circles show the women. 
Black plain lines shows median energy intake for men. 
Grey plain lines shows median energy intake for women. 
p-values are not calculated; patient-groups at the different visits are not the same (nine patients are the same).  
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For the nine patients who completed surveys at all visits (hospital, rehabilitation and home), 
individual energy and protein intake (development) is presented in Figure 6 and figure 7.  
 
 
Figure 6. Energy intake for individual 
patients who completed all visits (kcal) 
Graph presenting repeated measurements of the 
patients who completed all 24-h recalls. 
Grey lines = women, black lines = men. 
 
 
Figure 7. Protein intake for individual 
patients who completed all visits (kcal) 
Graph presenting repeated measurements of the 
patients who completed all 24-h recalls. 
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There was a significant increase in energy intake from hospital to rehabilitation for the 
patients who completed these visits (p = 0.02). There was an apparent, although not 
significant median increase in energy intake from hospital to home (p = 0.139) (Figure 8). 
The findings on changes in protein intake between visits were not significant, although there 
was a significant increase in protein intake as a percent of protein requirements between 
hospital and rehabilitation (p = 0.009) (Figure 9).  
 
 
Figure 8. Boxplots of changes in energy 
intake between hospital - rehabilitation, 
and hospital - home (kcal) 
Box = 25th and 75th percentiles; bars = min and max 
values.  
Vertical line spanning the figure represents zero 
change between hospital and rehabilitation and 
home, respectively.  
The Wilcoxon Signed ranked test is used to reveal 
significant changes between visits.  
Line over bars indicates no significant changes 
when (p > 0.05).  
 
Figure 9. Boxplots of changes in protein 
intake between hospital - rehabilitation, 
and hospital - home (grams) 
Box = 25th and 75th percentiles; bars = min and max 
values.  
Vertical line spanning the figure represents zero 
change between hospital and rehabilitation and 
home, respectively.  
The Wilcoxon Signed ranked test is used to reveal 
significant changes between visits.  
Line over bars indicates no significant changes 
when (p > 0.05).  
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3.4 Weight and anthropometric data 
Weight and anthropometric data was collected at hospital, during (n = 19) rehabilitation (n = 
15) and at home (n = 15), and are presented in Table 5.  
 
Table 5. Weight and body composition during the study period 
 
BMI = Body Mass Index, kg/m2. 
MUAC = Mid Upper Arm Circumference. 
BW = body weight. 
n.a. = Not available 
Data are presented as medians with interquartile ranges, and minimum and maximum values. 
Fat mass (FM) and Fat free mass (FFM) are calculated from BIA, with the formula of Kyle [95].  
Due to the severity of the patients, n varies between measurements. Not all patients were able to e.g. rise from 
the bed, unclothe etc.  
p-values are not calculated; patient-groups at the different visits are not the same (nine patients are the same in 
all visits). 
 
Median weight at hospital was 70 kg for men and 60 kg for women. Median BMI at hospital 
was 23.1 kg/m2 for men and 22.8 kg/m2 for women. At hospital, one patient had a BMI < 20.5 
kg/m2. The median weight for patients in rehabilitation was 67 kg for men and 59 kg for 
women. Median BMI in rehabilitation was 22.6 kg/m2 for men and 22.0 kg/m2for women. 
Three of 13 patients had a BMI < 20.5 kg/m2 at rehabilitation.  
 
n Median (IQR) min/ max n Median 
(IQR)




62                     
(59 - 69) 47 / 94 15
62               
(56 - 67) 47 / 86 15
64               
(56 - 66) 46 / 72
BMI, kg/m2 17 23.0                     
(22.5 - 24.3)
20 / 35 13 22.0               
(21.6 - 23.9)




27.3               
(27.0 - 29.0) 23.0 / 34.0 15
28.0               
(24.7 - 28.3) 21.2 / 34.5 15
28.0               
(27.0 - 29.3) 22.8 / 30.3
Triceps skinfold, 
mm 
14 15.0               
(14.0 - 16.0)
6.0 / 24.0 12 11.5               
(8.0 - 12.0)
4.5 / 17.0 14 11.5               
(9.0 - 15.0)
7.0 / 26.0 
Fat free mass, kg n.a. n.a. 10 40.4               
(37.4 - 48.9)
34.0 /50.5
Fat mass, kg n.a. n.a. 10
22.1               
(15.1-22.9) 11.5 / 30.0
Fat mass, % of BW n.a. n.a. 10
32.8               
(25.2 - 36.8) 23.0 / 43.1
Phase Angle, ° n.a. n.a 10
5.5               
(4.8 - 6.6) 4.2 / 7.5
A: hospital B: rehabilitation C: home
Weight development for patients who participated in more than one visit
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At home, the median weight was 66 kg for men and 60 kg for women. Median BMI was 23.8 
kg/m2 for men and 23.5 kg/m2 for women at home, and four of the patients had a BMI < 20.5 
kg/m2. BMI showed no correlation to strength or NMS. The median percentage of body fat 
(FM) was 23.7 % for the men and 35.5 % for the women. The median phase angle was 6.6° 
for the men and 5.3° for the women. There was an apparent positive association between BMI 
at the different visits and phase angle. There was also an apparent association between phase 
angle and percent weight loss (r = -0.714, p = 0.071). Plots for individuals weight at hospital, 
rehabilitation and home are shown in Figure 10.  
 
 
Figure 10. Weight for individuals during hospital, rehabilitation and home (kg) 
Scattered dot plot showing weight in kilos at hospital, rehabilitation and home for individuals. 
Black squares show the men, grey circles show the women. 
Black plain lines show median weight for men. 
Grey plain lines show median weight for women. 
p-values are not calculated; patient-groups at the different visits are not the same (eight patients are the same in 
all visits). 
  
















For the nine patients who completed all visits (hospital, rehabilitation and home), eight of 
them conducted all weight measurements, which is presented in Figure 11. Six of these eight 
patients lost weight during the post-operative period of their hip fracture. For these patients, 
median weight loss was apparently -2.5 kilograms (p = 0.075) from hospital to rehabilitation, 
and median -3.4 kilograms (p = 0.080) from hospital to home.  
 
 
Figure 11. Weight development for individual patients who conducted all visits (kcal) 
Graph presenting repeated measurements of the patients who completed all weight measurements. 
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Most of the current findings on changes in BMI and weight were not significant: the median 
change in BMI from hospital to rehabilitation was - 0.7 kg/m2 (p = 0.158) (Figure 12). This 
refers to a decrease of median 2.9 kg (p = 0.048) or 3.7 % of body weight (p = 0.056) after 
median 15 days. The median change in BMI from hospital to home was -0.8 kg/m2 (p = 
0.158), which was equivalent to a decrease of median 2.2 kg (p = 0.147) or 3.2 % of body 
weight (p = 0.182) after median 63 days. 11 out of 14 patients lost weight from hospital to 
rehabilitation, where six patients lost over 5 % of bodyweight. Eight out of 12 patients lost 
weight from hospital to home, where four patients lost over 5 % of body weight.  
 
 
Figure 12. Boxplots of changes in BMI between hospital - rehabilitation, and hospital - home 
BMI = body mass index, kg/m2. 
Box = 25th and 75th percentiles; bars = min and max values.  
Vertical line spanning the figure represents zero changes between hospital and rehabilitation and home, 
respectively.  
The Wilcoxon Signed ranked test is used to reveal significant changes between visits.  
Line over bars indicates no significant changes (p > 0.05).  
 
There was a significant decrease in triceps skinfold from hospital to rehabilitation, with a 
median of -3 mm in the total patient group (p = 0.04). Other than this, no significant changes 
were observed in triceps skinfold and mid-upper arm circumference measurements.  
  
31 
3.5 Nutritional risk screening 
From the easy nutritional screening conducted at the second visit (the four first questions of 
NRS 2002), 16 out of 20 patients were categorized as in nutritional risk (4/6 men, 12/14 
women). No patients had all four questions answered yes, while three patients had three 
question answered yes. The presentation of which questions are mostly answered yes are 
found in Table 6. An exploratory analysis was conducted to see whether the risk-group and 
non-risk-group varied in different variables, see Table 7.  
 
Table 6. Questions answered yes at the nutritional screening 
 
  
Is BMI < 20.5 kg/m2? 4
Has the patient lost weight within the 
last weeks? 14
Has the patient had a reduced dietary 
intake in the last weeks?
9
Is the patient severely ill? 0
Questions of NRS2002 n
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Table 7. Differences between groups with and without nutritional risk 
 
BMI = body mass index, kg/m2. 
LOS = Length of stay (at hospital) 
NMS = New mobility Score 
FFM = Fat free mass 
Quadriceps strength is measured with knee extension measurement 
Energy requirements were calculated by assuming 29 kcal/kg/day [51].  
For patients > 70 y: energy requirement was reduced with 10 %  [51]. 
Protein requirement were calculated by assuming 1.35 g/kg BW/day [49]. 
Any differences between groups are detected by Kruskall-Wallis test.  
  
Nutritional risk  
(n = 16)
Not in nutritional 
risk  (n = 4) p-value
Number of men / women 2 / 12 2 / 4 0.342
Age 82.0 74.5 0.477
BMI at hospital 23.1 23.0 1.000
BMI at rehabilitation 21.9 24.6 0.133
BMI at home 22.6 24.0 0.296
Energy intake at hospital, kcal 1130 1910 0.248
Protein intake at hospital, kcal 53 84 0.219
LOS 6 5 0.945
Phase Angle 5.5 5.4 0.600
Handgrip strength, kg 18 36 0.051
Quadriceps strength, kg 50 53 0.782
NMS 4 6 0.642
FFM, kg 40 50 0.068
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3.6 Strength and mobility  
Handgrip and quadriceps strength tests were performed when the patients were at home. 
Median grip strength for both sexes was 23 kg, and 38 and 18 kg for men and women 
respectively (right hand) (Figure 13). Handgrip strength was almost perfectly correlated to 
FFM (r = 0.973, p = 0.000), and significantly associated with protein intake at hospital (r = 
0.818, p = 0.024). Handgrip strength was seemingly correlated to new mobility score (r = 
0.542, p = 0.069) and phase angle (r = 0.424, p = 0.222), but not to weight loss, energy or 
protein intake beside protein intake at hospital.  
 
For quadriceps strength, median value was 51 kg for both sexes, 60 kg for men and 33 kg for 
women (Figure 14). Energy and protein intake at home was significantly correlated with 
quadriceps strength; r = 0.699 (p = 0.011) for energy intake and r = 0.720 (p = 0.008) for 
protein intake. Quadriceps strength also had an apparent positive association to protein intake 
at hospital (r = 0.703, p = 0.078). Quadriceps strength had a significant association to NMS (r 
= 0.633, p = 0.027) and an apparent, though not significant association to phase angle (r = 
0.469, p = 0.172).  
 
 
Figure 13. Handgrip strength at home 
showing right hand (kg) 
Scattered dot plot showing handgrip strength for the 
twelve patients who conducted that measurement. 
Black squares show the men, grey circles show the 
women. 
Black plain line shows median strength for men, 
grey plain line shows median strength for women. 
 
Figure 14. Quadriceps strength at home 
measured with knee extension (kg) 
Scattered dot plot showing knee extension for the 
twelve patients who conducted that measurement. 
Black squares show the men, grey circles show the 
women. 
Black plain line shows median strength for men, 
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NMS was conducted at rehabilitation (or home if visit at home was not carried out). Median 
score was 4.5 (of maximum 9 points) for the 18 patients who answered this. Ten of the 
patients reported that they were not able to do grocery shopping after returning home, while 
only one patient reported that this action was done effortlessly. Seven of the patients could not 
walk outside at all or without a helper, and nine of the patients were dependent on walking 
aids inside. There was a significant inverse correlation between NMS and age (r = -0.544, p = 
0.020). There was an apparent though not significant correlation between NMS and FFM (r = 
0.533, r = 0.112). There was no correlation between NMS and any other variable (energy- or 
protein intake, weight loss, phase angle, BMI, nutritional risk or blood values).  
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4 Discussion  
The aim of this observational study was to investigate energy and protein intake and weight 
development after a hip fracture in Norwegian patients. The main findings were a very low 
energy and protein intake at hospital where no patient reached the estimated requirements. 
Energy and protein intake at rehabilitation were higher but still insufficient, about two thirds 
of the patients did not meet estimated energy and protein requirements at rehabilitation and 
home. Eleven out of 14 patients lost weight from hospital to rehabilitation (median weight 
loss for the group was 2.9 kg, p = 0.048) and eight out of 12 patients lost weight from hospital 
to home (median weight loss for the group was 2.2 kg, p = 0.147). The low energy intake and 
the weight loss were the main reasons that 80 % of the patients were in nutritional risk at the 
rehabilitation phase of the hip fracture. This was a study that depended on the willingness of 
patients to be included, and as their motivation to participate was limited, a small number of 
patients were included. For this reason most findings did not achieve statistical significance, 
and therefore the results have to be interpreted with care.  
4.1 Energy intake and requirements  
The low energy intake at hospital in the present study (median 1200 kcal) is comparable as to 
what was found in a Swedish study of hip fracture patients where average daily energy intake 
during hospital days was 1300 kcal/ day, about 62 % of their estimated energy requirements 
[23]. In a somewhat older study from Switzerland, Jallut et al. also found comparable energy 
intake; mean 1100 kcal from day three to eight after surgery [24]. Both mentioned studies 
excluded patients with mental impairment, while a study that included these patients found an 
even lower energy intake three days after surgery (≈760 kcal) [28]. The mechanisms leading 
to insufficient nutrient intake in patients with hip fracture may be disease-related (pain and 
nausea) and/ or iatrogenic like fasting before and after surgery and interruption during 
mealtime. Also, unfamiliar hospital setting might lead to depressed mood and poor appetite 
[98]. Fear and anxiety after a hip fracture may also decrease energy intake. Catabolic 
conditions such as inflammation increases the nutrient requirement and thus increases the gap 
between energy intake and nutritional needs [52-54]. 
 
There are few other studies that have investigated energy intake, expenditure and weight loss 
in acute situations. Jallut et al measured REE by indirect calometry and found an estimated 
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daily energy deficit of mean -235 kcal at the third day after surgery and mean -13 kcal the 
eight day after surgery eight days after surgery, and no statistically weight loss was found 
[24]. This suggests that energy intake increased throughout hospital stay.  
 
It is difficult to estimate the energy deficit in the patients from the present study during their 
hospital stay, as we obtained only one 24 h recall, and did not assess energy expenditure. 
When using the estimated requirement of 29 kcal/ kg BW / day, and assuming that the energy 
intake as obtained by the 24 h recall remained the same throughout the hospital stay, and also 
assuming that weight loss was due to the catabolism of adipose tissue with an energy value of 
7,000 kcal/ 1 kg [99], an average weekly weight loss of 0.6 kg could have been expected. In 
fact, we observed a median weight loss of 2.9 kg from hospital to rehabilitation, which was on 
average covering a period of 16 days. Thus, other factors than low energy intake, most likely 
hypermetabolism due to inflammation, triggered the weight loss in the patients. This is also 
supported by the fact that was no correlations between energy intake and weight loss.  
 
The energy intake was significantly higher during rehabilitation than at hospital, but there was 
not a significant difference between the low energy intake at hospital and at home. The new 
mobility score in the present study revealed that about half of the patients were not able to do 
grocery shopping after returning to their own home, and for people living alone this could 
reduce food availability. Also, almost half of the patients were not able, or needed help from 
another person, to walk outside. Osnes et al. found that almost 30 % of hip fracture patients 
lost their ability to cook their own dinner, and 20 % lost their ability to prepare their own 
breakfast one year past fracture [22]. The physical limitations of the patients, found in our and 
other studies, could explain some of the low energy intake at home versus at rehabilitation, 
where all meals were prepared and served by the staff.  
4.2 Protein intake, breakdown and requirements 
As the protein intake during hospital stay was lower than the estimated requirement, a higher 
incidence of protein degradation versus protein synthesis was likely. Jallut et al found a 
negative protein balance based on urinary nitrogen excretion in hospitalized hip fracture 
patients at both days three and eight after surgery, -17.3 g and -24.3 g respectively. They 
found no weight loss during hospital stay, and energy intake increased during this period [24]. 
The low energy intake during hospital stay in the present study, confirmed by the weight loss 
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found, may have aggravated the protein breakdown, since circulating concentration of glucose 
must be obtained and amino acids become the main substrate for gluconeogenesis [100]. It 
should be of importance to investigate nitrogen balance and muscle loss in this patient group 
further, as it is not necessarily weight loss per se, but the loss of FFM which is mostly 
associated with adverse health outcomes [61].  
 
The proportion of protein in the diet was adequate at hospital and rehabilitation stay according 
to NNR recommendation of 15 - 20 E% protein for the elderly (>65 y) [1]. However, NNR 
emphasizes that at low energy intakes, below 1900 kcal/d, the protein E% should be further 
increased [1]. The high E% from protein in hospital and rehabilitation implies good meal 
planning at institution level, since the recommended protein E% for planning purposes in the 
elderly is 18 % [1]. It seems likely that the challenge is to get the patients to eat enough food, 
not necessarily a different balance between macronutrients in the meals being served.  
 
Protein recommendations for the elderly have until recently been based on findings on N-
balance, and have to a large extent concluded that adults and elderly have the same RDA. 
Recently this knowledge was put to test, and both ESPEN and NNR have now published that 
a higher protein intake should be recommended for the elderly, although some of the studies 
lack sufficient power to draw firm conclusions [49, 55, 101]. ESPEN also provided protein 
requirement for older adults with acute or chronic illnesses. They emphasised that elderly 
with inflammatory conditions can benefit from increased dietary protein intake, but further 
research is needed to identify and develop tools that can precisely define protein need in older 
sick individuals [49]. Hip fractures are associated with a development of an inflammatory 
response, but huge individual differences are found in inflammatory state, between 
individuals and time periods. Hence, there is probably massive variation regarding protein 
requirements in sick individuals, and the selected value for protein recommendation in this 
and other studies must be regarded as rough estimates.  
4.3 Weight development  
Weight loss in the elderly is associated with poor outcomes and increased mortality. 
Therefore, it was worrying that a third of the patients lost more than 5 % of body weight from 
hospital to home (median 9.5 weeks). A study from the UK reported that 24 % of the hip 
fracture patients had lost over 5 % body weight after eight weeks [102]. There was a 
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significant weight loss from hospital to rehabilitation of median 2.9 kg (p = 0.048), which 
corresponds to a decrease of 3.7 % of body weight (p = 0.158). It is stated that small weight 
losses, e.i 1 kg or 3% of body weight may be clinically important in frail elderly [65]. An 
unintentional weight loss of 4% - 5% of body weight within one year is associated with 
increased mortality and progressive disability [65]. The weight loss observed in the present 
study, although not all statistically significant, should therefore not be ignored.  
4.4 Nutritional risk and nutritional status 
The nutritional screening in the present study found that 80 % of the patients were in 
nutritional risk as measured during rehabilitation. This is by far a higher prevalence than in 
the general patient population in Haukeland University Hospital, were 35 % was in nutritional 
risk [6]. Although, these numbers are not directly comparable as we conducted the screening 
after hospital stay and have therefore included any consequences from disease state, while 
Tangvik et al. would capture any nutritional risk from before admission to hospital. Also, we 
did not conduct the whole screening as validated by ESPEN [5, 58]. Rather we used the first 
four questions of the NRS 2002 as proposed by Tangvik et al. They found that the four initial 
questions identified all the patients at nutritional risk in Haukeland University Hospital as 
compared to the more complex scoring questions of the complete NRS 2002. They concluded 
that this way of conducting nutritional risk will robustly identify nutritional risk and are a 
strong predictor of morbidity and mortality [6]. It is anyway a concern that 80 % of hip 
fracture patients are in nutritional risk after hospitalisation for a hip fracture. 
 
The differences between the nutritional risk and non-risk groups are not significant due to 
small sample sizes (Table 6), but they are presented to suggest further research and to 
describe a possible pattern. The higher ratio of men in the non-risk group can probably 
explain some of the apparently big differences between groups.  
 
Handgrip strength at 9.5 weeks post surgery was almost perfectly correlated to FFM in the 
present study, and is found to correlate well with overall muscle strength [80]. Handgrip 
strength for the men in the present study was not within the confidence interval for healthy 
men in the same age-interval [103], while the handgrip strength for the women were within 
their confidence limits [81]. Both handgrip strength and quadriceps strength in the present 
study had correlations related to energy intake, suggesting that patients with the highest 
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energy intake were the strongest. Also, strength measurements had apparent positive 
associations with PA, which could strengthen the theory that PA is a marker of overall health 
and nutritional status. 
 
The present study did not find any association between LOS and nutritional status as is found 
in other studies [57, 76, 88]. There was a big difference between LOS in the present study 
(median 6 days) compared to other Scandinavian and American studies who found 13, 14 and 
15 days, respectively [22, 23, 104]. As most patients in the present study were not sent 
directly home but to a rehabilitation stay for further care, it might be logical that nutritional 
status did not affect LOS at hospital.  
 
PA as a measure of overall health and nutritional status in increasingly recognized [105]. It 
was recently found to have negative relationship to LOS [76], although this was not 
prominent in the present study. We found a PA comparable to the reference values for the 
healthy elderly population [72], and one in seven women and one in three men were 
categorized as having low PA as presented by Kyle et al [78]. We found no differences in PA 
in patients with and without nutritional risk. It has to be noticed that other authors have 
questioned the use of the PA in the elderly, as it would merely reflect hydration level as high 
body cell mass. This would fit with our finding of an apparently high, although insignificant 
association between PA and percent weight loss, which could indicate that patients with the 
greatest weight loss had the highest PA. [70]. We assume that the reason for the high PA in 
patients with the greatest weight loss in the present study is explained by hydration level and 
chance, not necessarily by overall health and nutritional status. 
4.5 Methodological considerations 
4.5.1 Study strengths  
Hip fracture patients in the present study were thoroughly monitored during the acute and 
vulnerable phases after surgery. A longitudinal study during the acute and rehabilitation phase 
after a hip fracture has to our knowledge not been conducted in Norway until now, and it is 
important to perform such a study among different populations as the procedure for hospital 
and any rehabilitation stay for hip fracture patients vary between countries. We collected 
energy and protein intake and weight at three different phases, to compare and describe the 
development regarding these variables. 
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4.5.2 Statistical analysis 
As most of the data were not normally distributed, non-parametric tests were used in 
statistical analyses. Non-parametric tests are robust and handle extreme values well. On the 
other hand, they are not as sensitive as parametric tests, and the probability to detect marginal 
differences between data are thus lower. In general, non-parametric tests should not be used 
for dietary data as these are seldom normally distributed [106]. The dataset for the study 
contains a lot of missing data, due to high drop out rates. Thus, there was varying number of 
patients at each visit. After consulting a statistician, we decided not to conduct imputation of 
missing data since too many missing values would have had to be compensated for. 
4.5.3 Study sample and drop out rate  
We did not include patients with mental impairment, patients living in nursing homes, 
patients with previous hip fracture and who previously needed walking aids, which is a 
patient group in which other studies found even higher mortality and worse nutritional status 
than in healthier hip fracture patients [18, 107]. The dropout rate of 45 % (20 out of 42) is 
similar to what is found in studies on the same patient group, with dropout numbers at 47 % 
and 56 % [108, 109]. In the present study, patients who dropped out were apparently older 
and had lower energy intake at hospital than the patients who conducted more than one visit. 
It was reported that dropouts in a study of hip fracture patients were on average 5 years older, 
had a higher proportion of patients living alone and who used walking aids indoors [108]. It is 
reasonable to assume that the general health status of patients with hip fracture might be 
considerably worse than our findings would indicate, and that the dropout group is in worse 
physical condition than the remaining patient group.  
 
The present study had a relatively low number of patients. With a small n, any change in or 
difference between groups is hard to detect. A type II error occurs when found no effect in the 
population, when in reality, it is. The probability of this error (the β-level) increases when the 
number of patients is low [110]. Although we did not perform a formal power calculation 
before the study, due to the lack of reliable data, a post-hoc power calculation revealed that 
we would have needed 30 patients to detect a weight change of 3 % (assuming a SD of 5 %), 
or 80 patients to detect a change in BMI of one unit (kg/m2) (assuming a SD of 4 kg/m2). This 
explains the lack of statistical significance in our study.  
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4.5.4 Energy and protein intake 
The 24 h recall is normally carried out several times in order to capture a person’s diet. It is 
generally accepted that three 24 h recalls is optimal for estimating long-term energy intake 
[111]. This was however not our intention, we wanted to collect data regarding energy intake 
at three different stages after hip fracture surgery. Questions can therefore be asked regarding 
using the 24 h recall for our purpose, however, assessment methods that would demand more 
effort from the patients were unacceptable for this patient group. Some of the patients 
expressed that they had trouble remembering their food intake the previous day due to the 
difficulty of distinguishing one day from another at the hospital. The recommended method 
for monitoring energy intake in hospitalised patients is the staff administered dietary record 
[112]. However, we wanted to compare all collections, and therefore chose to use the same 
assessment method at all visits.  
 
There was a strong apparent association between the number of days after surgery the first 
visit was conducted, and energy intake, for men (r = 0.794, p = 0.059). This finding could 
suggest that the energy intake increases during the hospital stay as is found in other studies 
[23, 24], and could add doubt to our method for only conducting one 24-h recall during 
hospital stay. The estimated weight change from calculations found a weight loss in the 
present study, although not as big as the actual weight loss. This calculation confirms that the 
energy intake estimated by one 24 h recall and the estimated energy expenditure at hospital 
predicts a weight loss in the present population, and also provides an argument that energy 
intake maybe did not increase much during hospital stay in the present study. As the actual 
weight loss was higher than the theoretical estimate, closer monitoring during hospital stay 
and rehabilitation stay is encouraged.   
 
4.5.5 Weight and anthropometric data 
The patients were rarely weighted at admission to hospital and it was too painful for some 
patients to rise from the bed for weighting at the time of visit. For these patients self-reported 
weight was collected, and for elderly as for all age groups weight is often over-estimated or 
under-estimated [113]. Patients with self-reported weigh at hospital were included in the 
weight calculations as the patient number were quite low, and this could be a limitation of the 
study as we would not know whether these patients weight loss were true or not. However, 
the median weight loss appeared to be the same between the groups of self-reported and 
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weighted patients at the hospital; - 3 kg and -2.8 kg (p = 0.947) between hospital and 
rehabilitation, respectively. Between hospital and home, median weight loss was -2.1 kg in 
the group that self-reported weight at hospital, and -2.3 kg in the weighted group at hospital (p 
= 0.644). As the weight loss between groups were similar, it could imply that the weight loss 
of those who self-reported weight at hospital is actually true. 
 
Also, the data collected of triceps skinfold and MUAC at hospital could be unreliable since 
most patients were bedridden, and the manufacturers guidelines points out that patients should 
be standing for these measures. Therefore, these data has not been paid much attention. 
4.5.6 Further research 
Further research should aim to include a sufficient amount of hip fracture patients to be able 
to detect any significant changes between visits, and differences between groups. Also, hip 
fracture patients could be investigated thoroughly for a longer time (e.g 6 months) to see 
whether the acute adverse outcomes after a hip fracture are continuing, plateauing or 
decreasing. Further research should aim to find a reliable measure of body composition to 
investigate any changes in FFM, and include a more exact way of determining energy 
expenditure. When the acute and rehabilitation phase are better mapped, interventions should 
be initiated to decrease the gap between energy / protein intake and requirement. Energy and 
protein intake and weight development should be monitored of all hip fracture patients, not 
only those who were healthy before the fracture to get more representative data. The optimal 
energy and protein requirement for this population requires further research is necessary.  
4.6 Conclusion  
In conclusion, energy and protein intake was very low in hospitalised hip fracture patients, 
and remained sub-optimal during rehabilitation and after returning home. A significant weight 
loss and a high number of patients in nutritional risk, suggest that the patients in the present 
study experienced a critical phase, and this issue should be investigated further  
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Forespørsel om deltakelse i forskningsprosjektet 
 
”Helseeffekt av fisk- eller kjøttinntak hos eldre 
hoftebruddspasienter” 
 
Bakgrunn og hensikt 
Dette er et spørsmål til deg om å delta i en forskningsstudie for å se på 
helseeffekten av å spise fisk eller kjøtt etter at man har hatt et 
hoftebrudd, og du har nylig hatt et slikt brudd. Vi er spesielt interessert 
i å se på det som har med din helse og funksjon å gjøre, for eksempel 
hvilke sammenheng det er mellom det du spiser og din muskelmasse. 
Klinisk institutt ved Universitetet i Bergen i samarbeid med Haukeland 
Universitetssykehus er ansvarlig for studien. 
 
Hva innebærer studien? 
Deltagelse i studien innebærer at du blir valgt ut til og enten spise fisk 
eller kjøtt 4 ganger pr uke i 16 uker. Råvarene til middag og fisk/kjøtt 
som pålegg vil bli levert hjem til deg. Ved studiens start, underveis og i 
slutten vil vi ta noen målinger av deg, blant annet blodprøver, vekt, 
høyde og blodtrykk. Vi vil gjøre analyser av gener (genetiske varianter) 
som kan ha sammenheng med hoftebrudd og proteininntak. Vi vil også 
teste din muskelmasse og muskelstyrke. Dette gjøres ved hjelp av 
enkle øvelser, et spørreskjema og bioelektrisk impedansemåling. Det 
siste er en metode hvor to elektroder festes til hver fot og hånd. Du vil 
ikke kjenne noe under denne undersøkelsen. Hvis du har 
pacemaker/defibrillator kan du ikke gjennomgå denne delen av 
undersøkelsen. Vi vil også intervjue deg ang ditt matinntak siste 
døgnet og om hvordan matlysten din har vært siste tiden. Vi vil også 
reise hjem til deg eller ringe ukentlig underveis i studien, både for å 
bringe deg mat og for å høre hvordan det går med deg. Vi er spesielt 
opptatt av om du har falt siste uke og om du klarer å spise maten du 
har fått av oss.   
 
Hvis du samtykker til å delta i studien ønsker vi å registrere 
opplysninger om deg som rutinemessig samles inn i forbindelse med 
ditt sykehus- og rehabiliteringsopphold. De fleste opplysninger vil være 
tilgjengelig fra din sykehusjournal, men vi ønsker også å benytte 
                                                    
opplysninger fra Nasjonalt hoftebruddsregister angående 
din selvrapporterte livskvalitet.  
 
Mulige fordeler og ulemper 
Du vil få fisk eller kjøtt tilsvarende to middagsporsjoner og pålegg til 
brødmåltider pr uke levert hjem til deg. Du må selv tilberedet to 
middager pr uke av disse råvarene. Hvis du havner i kjøttgruppen, har 
du lov å spise fisk til middag en gang per uke, men ikke oftere. Hvis du 
havner i fiskegruppen har du lovt til å spise fisk til middag en gang til 
middag utover de to fiskemåltidene du får av oss. Hvilken gruppe du 
havner i, blir tilfeldig og kan ikke påvirkes av oss eller deg.  
 
Hva skjer med prøvene og informasjonen om deg?  
Prøvene tatt av deg og informasjonen som registreres om deg skal 
kun brukes slik som beskrevet i hensikten med studien. Alle 
opplysningene og prøvene vil bli behandlet uten navn og 
fødselsnummer eller andre direkte gjenkjennende opplysninger. En 
kode knytter deg til dine opplysninger og prøver gjennom en navneliste 
som er hold hemmelig og innelåst.  
 
Det er kun autorisert personell knyttet til prosjektet som har adgang til 
navnelisten og som kan finne tilbake til deg. Etter studieslutt i januar 
2020, vil informasjonen om deg avidentifiseres. Prøvene vi har tatt av 
deg og opplysninger fra intervjuer og sykehusopphold vil med din 
tillatelse bli oppbevart i en biobank. Det vil ikke være mulig å 
identifisere deg i resultatene av studien når disse publiseres eller blir 
offentliggjort på andre måter.  
 
                                                    
 
Frivillig deltakelse 
Det er frivillig å delta i studien. Du kan når som helst og uten å oppgi 
noen grunn trekke ditt samtykke til å delta i studien. Dette vil ikke få 
konsekvenser for din videre behandling. Dersom du ønsker å delta, 
undertegner du samtykkeerklæringen på siste side. Om du nå sier ja til 
å delta, kan du senere trekke tilbake ditt samtykke uten at det påvirker 
din øvrige behandling. Dersom du senere ønsker å trekke deg eller har 
spørsmål til studien, kan du kontakte Professor Jutta Dierkes eller 
klinisk ernæringsfysiolog Hanne Rosendahl Gjessing på telefon 
55973085 (mellom kl 8-15.30). 
 
Ytterligere informasjon om studien finner du på neste side. 
Deretter følger informasjon om biobank, personvern og 
forsikring. 
  
Samtykkeerklæring finner du på siste siden, og den må du 
signere for å delta i studien.
Eldre med hoftebrudd  
Utfyllende informasjon om studien 
Kriterier for deltakelse 
o Over 65 år og innlagt for første hoftebrudd 
o Bor hjemme før hoftebruddet  
o Kunne gå uten hjelpemiddel før hoftebruddet 
o Kunne signere et informert samtykke 
• Bakgrunnsinformasjon om studien 
o Hensikten med studien er å undersøke om fisk- eller 
kjøttinntak påvirker helsen etter et hoftebrudd. Spesielt ønsker 
vi å undersøke endringer i muskelmasse og funksjon etter 
bruddet.   
• Følgende undersøkelser du må gjennom i studien: blodprøver, 
urinprøve, veiing, måling av høyde (eller tilsvarende), gripestyrke, 
kneekstensjon, måling av muskelmasse vha bioimpendansemåling, 
hudfoldsmåling, kostholdsintervju og intervju ang din vektutvikling 
og matinntak 
• Tidsskjema – hva skjer og når skjer det? 
o Under sykehusoppholdet 
! Signere samtykket og bli inkludert i studien 
o Når du er på rehabiliteringsopphold 
! For noen deltakere: en prosjektmedarbeider vil ta ekstra 
blodprøver og intervjue deg om ditt kosthold under 
rehabiliteringsoppholdet 
! Vi kontakter deg når du har kommet hjem fra oppholdet, 
3-8 uker etter utskrivelse fra sykehus 
o Når du kommer hjem og 16 uker deretter 
! Studien starter, og du vil gjennomgå alle tester som 
nevnt og starte og spise fisk/kjøtt i 16 uker. For noen 
pasienter vil det bli tatt blodprøve og kostholdsintervju 
etter 4 uker. For alle vil det bli gjort nye tester etter 16 
uker.  
• Mulige fordeler 
o Du vil få gratis fisk eller kjøtt til middag 2 ganger og pålegg til 
to måltider pr uke i 16 uker  
• Mulige ubehag/ulemper 
o Du må ta ekstra blodprøver i tillegg til de du tar når du er 
innlagt 
Eldre med hoftebrudd  
o Du må tilbedre middag av råvarene du får hjem til deg 2 
ganger pr uke 
• Pasientens ansvar 
o At du spiser maten som avtalt ved studiestart 
• Pasienten vil bli orientert så raskt som mulig dersom ny 
informasjon blir tilgjengelig som kan påvirke pasientens villighet til 
å delta i studien 
• Pasienten skal opplyses om mulige beslutninger/situasjoner som 




Personvern, biobank, økonomi og forsikring 
 
Personvern 
Opplysninger som registreres om deg er helseopplysninger fra din 
journal på Haukeland Universitetetssykehus eller Haraldsplass 
Diakonale sykehus. I tillegg vil vi innhente informasjon om følgende: 
vekt, høyde, blodtrykk, blodprøver, urinprøver, fysisk funksjon, 
kosthold, kroppssammensetning. 
 
Universitetet i Bergen ved administrerende direktør er 
databehandlingsansvarlig. 
 
Utlevering av materiale og opplysninger til andre 
Hvis du sier ja til å delta i studien, gir du også ditt samtykke til at 
prøver og avidentifiserte opplysninger utleveres til samarbeidende 
universiteter i EU og USA. Dette kan være land med lover som ikke 
tilfredsstiller europeisk personvernlovgivning. 
 
Biobank 
Blod- og urinprøvene vil med din tillatelse bli lagret i en 
forskningsbiobank ved Hormonlaboratoriet, Haukeland 
Universitetssykehuset. Hvis du ikke vil delta i denne studien kan du 
allikevel samtykke til at vi lagrer det biologiske materialet i en 
biobanken. Informasjon om forskningsprosjekter det biologiske 
materialet en gang kan benyttes i vil du finne på følgende 
internettside: http://www.helse-
Eldre med hoftebrudd  
bergen.no/omoss/avdelinger/hormonlaboratoriet/Sider/forskning-og-
utvikling.aspx. Du kan også få utdelt skriftlig informasjon om 
biobanken. Overlege/professor Gunnar Mellgren er 
ansvarshavende for forskningsbiobanken. Det biologiske materialet 
kan bare brukes etter godkjenning fra Regional komité for medisinsk 
og helsefaglig forskningsetikk (REK).  
 
Rett til innsyn og sletting av opplysninger om deg og sletting av 
prøver  
Hvis du sier ja til å delta i studien, har du rett til å få innsyn i hvilke 
opplysninger som er registrert om deg. Du har videre rett til å få 
korrigert eventuelle feil i de opplysningene vi har registrert. Dersom 
du trekker deg fra studien, kan du kreve å få slettet innsamlede 
prøver og opplysninger, med mindre opplysningene allerede er 
inngått i analyser eller brukt i vitenskapelige publikasjoner.  
 
Økonomi  
Studien og biobanken er finansiert gjennom forskningsmidler fra 
Fiskeri- og havbruksnæringens forskningsfond (FHF). FHF har 
ingen innflytelse på det vitenskapelige oppsettet, tolking eller 
publisering av resultatene fra studien.  
 
Forsikring 
Ved deltagelse i studien eller hvis du bidrar til biobanken, har du 
rettigheter i forhold til Pasientskadeerstatningsloven.  
 
Informasjon om utfallet av studien 
Som deltager i studien har du rett til å få informasjon om resultatet av 
studien. 
 
Eldre med hoftebrudd  
Samtykke til deltakelse i studien og/eller biobank 
 
  Jeg er villig til å delta i studien  
 
  Jeg er villig til at biologisk materiell lagres i en biobank 
 
  Jeg er villig til å delta i studien og at det lagres biologisk materiell 




(Signert av prosjektdeltaker, dato) 
 










% % % %
%
%
% % % %
%
%
% % % %
%
%
% % % %
%
%
% % % %
%
%















































Mat og helse henger nøye sammen. I Helse Bergen har vi utviklet en ernæringsstrategi som vi mener 
vil være en viktig del av behandlingen. 
 
Når pasientene er innlagt hos oss, er det derfor viktig at de screenes / vurderes med hensyn til 
ernæringsstatus. På den måten kan vi identifisere de pasientene som er i en ernæringsmessig risiko slik 
at de kan få den ernæring og behandling de trenger. 
Det er derfor utviklet retningslinjer for screening av pasienter og vi har et screeningverktøy som vil 
være et godt hjelpemiddel. 
Det er ønskelig at screeningen skjer når pasientene legges inn, slik at en eventuell 
ernæringsbehandling kommer i gang så tidlig som mulig og kan integreres i den helhetlige 
behandlingen. 
Det forventes at de faglige retningslinjene følges. Ved å gjøre det, oppfylles kravet om faglig 
forsvarlighet i lovverket.  
Dersom noen av en eller annen grunn velger løsninger som i vesentlig grad avviker fra retningslinjene, 
må dette dokumenteres og det må gis en begrunnelse for det valget som er tatt. 
Ledelsen i Helse Bergen legger stor vekt på ernæringsstrategien og de positive virkningene den har for 
pasientene våre. Jeg håper og tror at alle ansatte vil følge opp strategien og de føringene som legges i 
de retningslinjene som er utarbeidet. 
 
Stener Kvinnsland 














”God ernæringspraksis. Retningslinjer for ernæringsbehandling i Helse Bergen HF” er utarbeidet på 
oppdrag fra Ernæringsrådet i Helse Bergen av:  
 
Leder:  Anne Berit Guttormsen, overlege, dr. philos Intensivavd 
Berit Falk Dracup, klinisk ernæringsfysiolog, sjef for Avdeling for klinisk ernæring 
Lene Botnen Huus, sykepleier, Kir Avd 
Borghild Ljøkjell, lege, ØNH 
Rune Svensen, overlege, Kir Avd 
Randi J Tangvik, klinisk ernæringsfysiolog/ernæringskoordinator FoU-Avd (sekretær) 
 
Høringsinstans: 
Nivå-2-lederne for kliniske avdelinger i Helse Bergen HF 
Ernæringsfaglederne i Helse Bergen 
Avdeling for klinisk ernæring Helse Bergen  
Avdeling for klinisk ernæring Helse Stavanger 















Forskning viser med stor tyngde at en forbedret ernæringsbehandling 
 
1. Kan forbedre og hindre reduksjon i mental og fysisk helse. 
2. Kan redusere antall komplikasjoner som følge av sykdom og behandling.  
3. Kan redusere rekonvalesenstiden.  
4. Kan forkorte liggetiden på sykehuset og redusere behovet for primærhelsetjenester. 
 
Det er mange årsaker til sykdomsrelatert underernæring, men redusert matinntak synes å være en klar 
hovedårsak.  
 
Alle pasienter som innlegges i Helse Bergen skal screenes i forhold til ernæringsmessig risiko. Som 
screeningverktøy anbefales NRS 2002 (Nutritional Risk Screening), i norsk oversettelse ”God 
ernæringspraksis – vurdering av ernæringsmessig risiko”. Dette er enkelt i bruk, det innbefatter høyde, 
vekt og tar hensyn både til ernæring og stressmetabolisme. 
 
Primærscreeningen består av fire spørsmål som stilles opp ved innkomst til sykehuset, fortrinnsvis av 
sykepleier i innkomstsamtalen. Svarene avgjør om den grundigere hovedscreeningen skal utføres. 
Tiltak hos pasienter i ernæringsmessig risiko gjennomføres i et samarbeid mellom leger, sykepleiere 
og kliniske ernæringsfysiologer. Fokuser på måltidene, server tilstrekkelig antall måltider i et 
stimulerende spisemiljø. Berik maten til småspiste pasienter. Skjerm måltidet. Næringsdrikker brukes 
for å øke energitilførselen, men skal ikke erstatte måltidene. 
 
Enteral ernæring tilføres via nasogastrisk sonde, PEG eller jejunumkateter i tilfeller hvor pasienten 
ikke ved egen hjelp kan ta til seg tilstrekkelig ernæring. Ved for liten energitilførsel enteralt suppleres 
med parenteral ernæring i de tilfeller hvor pasientens leveutsikter eller livskvalitet signifikant kan 
bedres av slik behandling.  
 
Ernæringsbehandlingen skal sees i sammenheng med de fire etiske grunnprinsippene:  
 
1. Beneficiens: Å gjøre godt, balansere nytte mot risiko  
2. Non maleficiens: Å avstå fra å gjøre skade  
3. Autonomi: Pasienten har rett til medbestemmelse og informert samtykke  
4. Justis: Rettferdig fordeling av ressurser i forhold til nytte og risiko  
 
Det grunnleggende mål for all behandling og omsorg, herunder oral, enteral eller parenteral ernæring 
må være at tiltakene alltid iverksettes i pasientens beste interesse, og at fordelene ved tiltakene 
oppveier både ulemper og risiko. Det vil oppstå situasjoner hvor det enten er etisk riktig å unnlate å 
starte en ernæringsbehandling, eller avslutte en allerede påbegynt behandling.  
 
ICD10-koden E46-Protein- og energiunderernæring gis til pasienter i ernæringsmessig risiko (score 
≥3) som har fått ernæringsbehandling under sykehusoppholdet. 
  4
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1. Innledende screening  
 
Innledende screening skal gjennomføres på alle pasienter. 
 
  JA NEI 
1 Er BMI < 20,5?   
2 Har pasienten tapt vekt i løpet av de siste ukene?   
3 Har pasienten hatt redusert næringsinntak de siste ukene?   
4 Er pasienten alvorlig syk?   
JA:     Dersom svaret er ”JA” på ett eller flere av disse spørsmål, gjennomføres  hovedscreening 
NEI:   Dersom svaret er ”NEI” på alle spørsmål, gjennomføres ny risikoscreening om én uke. 
           NB! Resultatet av all screening skal dokumenteres i ”God ernæringspraksis-journalark” 
 
Opplysningene innhentes på alle voksne pasienter ved innkomst i avdelingen. De skal føres i 
journalarket ”God ernæringspraksis” av sykepleier eller lege og oppbevares tilgjengelig under hele  
innleggelsen i kurvebok. Ved utskriving skannes og lagres journalarket i Doculive kapittel F2. 
 
 
Spørsmål 1 (”nå-situasjonen”) 
BMI (= Body mass index = KMI =  kroppsmasseindeks) gir en rask vurdering av protein- og 
energistatus basert på individets høyde og vekt. Bestem høyde (mål høyde, se i journalen eller spør 
pasienten) og vei pasienten for å kalkulere BMI (kg/m2), eller bruk BMI-tabell. 
 
BMI < 18,5:   Lav protein/energistatus er sannsynlig 
BMI 18,5 – 20,5:  Lav protein/energistatus er mulig 
BMI > 20,5:  Lav protein/energistatus lite sannsynlig 
 
 
Spørsmål 2 (stabil/ustabil tilstand?)  
Vekttap: JA/NEI. Ufrivillig vekttap over en periode på 3-6 mnd er en mer akutt risikofaktor for 
underernæring enn BMI. Hvis vekten ikke er journalført, spør pasienten hva han/hun veide før de ble 
syke, eller for 3-6 mnd siden. Sammenlign dette med aktuell vekt. 
 
 
Spørsmål 3. (vil situasjonen forverres?) 
Spist lite: JA/NEI. Har pasienten spist mindre enn normalt de siste dagene/ukene før 
sykehusinnleggelsen? Har pasienten kostrestriksjoner som medfører et ensidig kosthold? Har 
pasienten svelgproblemer? Har pasienten redusert appetitt? 
 
 
Spørsmål 4. (vil sykdomsprosessen akselerere situasjonen?) 
Alvorlig syk: JA/NEI Har pasienten en kronisk sykdom eller en sykdom som sannsynligvis vil 
påvirke matinntaket? Skal pasienten gjennom et større kirurgisk inngrep eller få annen behandling som 
vil medføre redusert næringsinntak og økte behov? 
  
 
Resultat av innledende screening: 
Dersom svaret er JA på ett eller flere spørsmål, gå videre til hovedscreening 
Dersom svaret er NEI på alle spørsmål, screeningen er ferdig, men skal repeteres om en uke, dersom 
pasienten fremdeles er inneliggende. 
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Gjennomføres hos pasienter som fyller minst ett av kriteriene i innledende screening. 
 
1. Gi score: 
Score Ernæringstilstand Score Sykdommens alvorlighetsgrad 
0 Normal ernæringstilstand 0 Ikke syk 
1 Vekttap > 5 % siste 3 mnd eller  
Matinntak 50-75% av behov siste uke 
1 Kronisk sykdom eller 
gjennomgått mindre kirurgisk 
inngrep 
2 Vekttap > 5 % siste 2 mnd eller 
BMI = 18,5 – 20,5 + redusert allmenn- 
tilstand  eller  
Matinntak 25-50% av behov siste uke 
2 Tydelig redusert allmenntilstand 
pga sykdom 
3 Vekttap > 5 % siste måned (> 15 % 
siste 3 mnd) eller 
BMI < 18,5 + redusert allmenntilstand 
eller 
Matinntak 0-25 % av behov siste uke  





Sammenlign aktuell vekt med tidligere vekt. Kalkuler sykdomsrelatert vekttap: 
 
Prosent vekttap = vekttap i kg x 100/ opprinnelig vekt i kg 
 
Vekttap < 5 % siste 3 mnd: Innenfor normalvariasjon 
Vekttap > 5 % siste 3 mnd: Tidlig indikator på risiko for underernæring 
Vekttap > 5 % siste 2 måneder: Klinisk signifikant vekttap 
 
 
    
2. Summér score: 
    
   Score for ernæringstilstand:   0-3 
+ Score 1 for alder > 70 år:    0-1 
+ Score for sykdommens alvorlighetsgrad:  0-3 
= Risikoscore      0-7 
 
 
Score 0-2: Pasienten er ikke i ernæringsmessig risiko. Dokumenter at screening er utført. Angi 
resultatet på journalarket for senere skanning til journal. Gjenta innledende screening etter 1 uke. 
 
Score > 3: Pasienten er i ernæringsmessig risiko. Lag ernæringsplan. 
 












1. Beregn kaloribehov: 30 kcal/kg/døgn 
 
Modifikasjoner: Sengeliggende 29, oppegående 33, i oppbyggingsfase 40 (kcal/kg/døgn) (21). 
Tilpass individuelt: 
• Mager pasient:  Øk med 10 % 
• Alder 18-30 år: Øk med 10 % 
• Alder > 70 år: Reduser med 10 % 
• Overvektig: Reduser med 10 % 




2. Beregn væskebehov: 30 -(40) ml/kg/døgn   
 




3. Sett mål 
 
Målrettet ernæringsbehandling skal ha en start og en slutt. 
Forsiktig oppstart: De fleste pasienter, og spesielt de som har spist lite den siste tiden, kan trenge 
gradvis opptrapping av næringsinntaket.   
Stabil vekt eller vektøkning: Ved behov for vektøkning, sett også mål for når ønsket og realistisk 
vektøkning skal nås. Observer toleranse/komplikasjoner og vektutvikling for å avgjøre om planen kan 
følges eller må justeres. 
”Energikick”: Det kan være et mål at pasienten får i seg så mye næring som mulig under 
sykehusoppholdet, og at ernæringen seponeres ved utskrivning. Et høyt energiinntak noen dager gir 
bedre appetitt etter seponering, og kan bedre pasientens forutsetning for å klare seg selv etter 
utskrivning. 






4. Kartlegg og, om mulig, korriger faktorer som innvirker på matinntaket  
 
Liten appetitt, kvalme, fort mett, smerter, svelgvansker, munnsårhet, fordøyelsesproblemer (diare, 
obstipasjon, gass, annet), maten smaker ikke/smaker annerledes, liker/liker ikke, dyspnoe osv. 
 
Hva skal gis? Kosttilskudd, beriking eller kunstig ernæring?  
Hvordan skal det gis? Peroralt, enteralt, parenteralt eller en kombinasjon? 
Vurder behov for opptrappingsplan. 
 
Vurder behov for klinisk ernæringsfysiolog, logoped (utredning av svelgevansker) ergoterapeut 
(tilrettelegging) eller en egnet lege for vurdering mtp parenteral ernæring.  
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5. Gi ICD10 diagnosekode: E46 Protein- og energiunderernæring  
Kriterier: Ernæringsscore >3 og gjennomført ernæringsbehandling under sykehusoppholdet (beriket 
eller på annen måte tilpasset kosthold, systematisk bruk av næringsdrikker, sondeernæring, parenteral 




6. Henvis til klinisk ernæringsfysiolog og evt medisinsk spesialist 
• Hvis sykdom eller symptomer tilsier behandling med terapeutisk diett 
• Hvis pasienten har intoleranse/allergier som gjør det vanskelig å tilpasse sykehuskosten 












Sørg for frisk luft og ryddig spiseplass. La pasienten vaske hender og gjerne ansikt og hals før 
måltidet. Ivareta munnstell før og etter måltidet. Legg vekt på at maten skal se frisk og appetittlig ut. 
Legg på litt farge, f. eks appelsinskive, tomat, druer eller lignende.  Ved dårlig appetitt tilbys små 
porsjoner, med mulighet for påfyll. Del opp store biter og hele skiver. Bestikk, glass og servise skal se 
pent ut, uten skjolder og høy slitasje.   
 
 
2. Matomsorg  
Vis omtanke og server maten på en hyggelig måte. Sørg for at maten ser innbydende ut. Tilby 
smaksforsterker (salt, krydder), alternativ mat eller spisehjelp hvis pasienten ikke vil/kan spise, og 
påfyll til de som har spist opp.  Pasienter som ikke klarer å spise tilstrekkelig, kan trenge hjelp til å 




Gi pasienten rett type kost. Ta utgangspunkt i sykehusets normalkost og tilpass denne til pasientens 
ønsker og behov eller bestill spesialkost.  Ved dysfagi/svelgproblemer, velg konsistenstilpasset kost 
(moset, flytende eller geleringskost), og vurder henvisning til logoped for utredning. Velg energi- og 
næringstett (EN-kost) kost til småspiste pasienter. Ved ulike former for kostrestriksjoner, bestill 
spesialdiett og vurder henvisning til klinisk ernæringsfysiolog.  
 
Server tilstrekkelig antall måltider. Hvis pasienten spiser lite, er mellommåltider desto viktigere. 
Unngå nattlig faste over 11 timer. Vurder behov for tilskudd og beriking i form av energi, protein, 




Når det er behov for næringsdrikk, skal den helst komme i tillegg til vanlig mat. Tilby først det vanlige 
måltidet og avslutt med næringsdrikk. Næringsdrikk gir et viktig tilskudd av energi og næringsstoffer. 
Se til at den blir drukket. Det er bedre å gi litt næringsdrikk i et glass framfor å sette fram hele 
pakningen dersom den likevel ikke drikkes opp. Velg en med høyt energiinnhold per ml. Velg en smak 
pasienten liker. Tilby evt flere smaker. Serveres godt avkjølt. 
 
  
5. Kostregistrering  
Hvis det er tvil om pasienten trenger støttebehandling i form av enteral eller parenteral 
ernæringsbehandling, gjennomføres kostregistrering for å skaffe dokumentasjon. Kostregistrering er 
en detaljert nedtegnelse av hva og hvor mye pasienten har spist i løpet av en dag. Dette må utføres 
nøyaktig og fullstendig for at det skal ha noen verdi. Bruk en lyntabell (fås hos Avdeling for klinisk 
ernæring) til å beregne energiinnholdet i maten. Vær oppmerksom på at både pasienten selv og ansatte 




6. Henvis til klinisk ernæringsfysiolog  
• Hvis det er tvil om hvilken mat pasienten skal tilbys 
• Hvis det oppstår problemer med å få bestilt/levert riktig mat til pasienten  
• Hvis det er behov for kostveiledning. 
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5. Enteral ernæring 
 
 
Enteral ernæring forutsetter intakt mage-tarmkanal og brukes der peroralt inntak av en eller annen 




1. Administrasjonsveier  
Nasogastrisk sonde ved behov for enteral ernæring i inntil 2-4 uker. 
 
Nasojejunal sonde ved risiko for aspirasjon, f. eks ved gastroparese/ventrikkelretensjon, hyperemesis, 
etter abdominal kirurgi, kritisk syke. 
 
Gastro- eller enterostomi ved behov for ernæring > 2-4 uker. Velg fortrinnsvis PEG (perkutan 
endoskopisk gastrostomi). Ved risiko for aspirasjon eller oppkast, velg PEJ (perkutan endoskopisk 
jejunostomi) eller JET-PEG (jejunaltube-PEG). Gi forebyggende råd om hudstell for å unngå 
infeksjon ved gastrostomiporten og behandling av granulasjonsvev (”villkjøtt”). Vurder henvisning til 
stomisykepleier.  
 











Innhold per 100 ml 
 
Bruk 
Standard, med og uten fiber 100 kcal, 4 g protein Kan brukes til de fleste. Fiber bedrer fordøyelsen 
og forebygger obstipasjon. 
Energirik, med og uten 
fiber 
150 (120-200) kcal,  
6 (5,6 – 7,5) g protein 
Væskerestriksjon eller forhøyet energibehov.  
Fiber bedrer fordøyelsen og forebygger 
obstipasjon. 
Lavenergiløsninger 75 og 80 kcal  Redusert energibehov. NB: noen av løsningene har 
tilsvarende redusert nivå av mikronæringsstoffer 
Komprimert 120 kcal, 5,5 g protein 
Forhøyet nivå av 
mikronæringsstoffer  
Væskerestriksjon og redusert energibehov 
Lavt elektrolyttnivå 25-100 mg Na, 50-180 mg K, 
25-80 mg Cl,35-75 mg P 
Aktuelt ved nyre-, lever-, hjertesvikt 
Proteinrik 6-7,5 g protein Forhøyet proteinbehov ved metabolsk stress, 
sårtilheling etc. 
Peptidbasert med MCT 
 
Proteinet er hydrolysert til 
peptider. Det finnes også en 
ren aminosyreløsning. 
Malabsorpsjon, f.eks Mb Crohn eller 
korttarmsyndrom. 
Andre spesialløsninger Tilpasset ulike sykdommer Intensiv: Tilsatt ekstra glutamin og n-3-fettsyrer 
Melkeintoleranse: Soyabasert 
Diabetes: Vanligvis velges standard sondeløsning 
med fiber, men det finnes spesialing som er 




Retningslinjer for ernæringsbehandling i Helse Bergen HF 
 
 
Liggesår: Det finnes sondeløssning beriket med 
protein, vit C og E, sink, selen, karotenoid og 
arginin for bedre sårtilheling 
Diaré/fettmalabsorpsjon: Sondeløsninger med 
MCT-fett for bedre absorpsjon.   
 
 
3. Oppstart med sondeernæring 
For effektiv ernæringsbehandling er det best å komme i gang så tidlig som mulig, og å komme opp i 
beregnet behov så rask som mulig. Gradvis tilvenning er likevel nødvendig, og toleranse må oppnås 
før opptrappingen fortsetter. Ernæringstilførsel v.hj av ernæringspumpe er å foretrekke. 
  
 





















100-400 ml ila 10-30 min 




Gir færre komplikasjoner, sjeldnere refluks, mindre magesmerter 
og diaré. Foretrekkes til de svært syke og de som har vært lenge 
uten mat i tarmen.  
En nattlig pause på 4 timer kan fremme bedre fordøyelse 
ettersom pH i magesekken normaliseres ila av denne tiden. 
 
Mer fleksibelt for pasienten,  
 
Til stabile pasienter. Ligner mest på ordinært måltidsmønster og 
kan være fysiologisk best.  
Hvis maten gis for fort eller i for store mengder kan det medføre 
diaré, magekrampe, kvalme, oppblåsthet og magesmerter. 
 
Hvis sonden ligger i jejunum, kan kontinuerlig tilførsel med pumpe redusere grad av diare og 
aspirasjon. 
 
Ved å heve sengens hodeende til 30-45 grader under sondetilførselen kan risikoen for aspirasjon 
reduseres. 
 
Maten bør ikke fortynnes ved oppstart. Dette kan forsinke begynnelsen på en positiv nitrogenbalanse 
og kan se ut til å øke forekomsten av diare, krampe og ubehag. 
 
Infusjonshastigheten kan økes raskt til ønsket hastighet. Begynn med infusjonshastighet 25 ml/time de 
første 8 timer. Dersom pasienten tåler, dette øk med 25 ml/time hver 8. time til maksimalt 150 




Feilplassert sonde: Er man usikker på riktig plassering av sonde, bør dette kontrolleres med røntgen. 
Sår: Bruk tynne, myke sonder i vevsvennlig materiale for å unngå mekaniske sår. 
Okklusjon av sonde: Ved kontinuerlig tilførsel kan det også være nødvendig å ta en pause for å  
skylle sonden etter 6-8 timer. Unngå bruk mandreng til å åpne tett sonde pga av faren for perforasjon. 
Refeeding syndrome med hypofosfatemi, hypomagnesemi, hypokalemi, tiaminmangel og  
væskeretensjon. Ernæringsterapi trappes opp langsomt hos pasienter som ikke har hatt adekvat  
ernæringstilførsel over lengre tid. Korriger elektrolyttene og gi tiamintilskudd: 250 mg  
intramuskulært pr dag i 2 dager, deretter 100 mg tablett per os under sykehusoppholdet. 
Overfeeding syndrom med CO2-retensjon og feber skyldes for høy kaloritilførsel. 
Aspirasjon kan unngås ved å legge sonden ned i tynntarmen og gi kontinuerlig  




Retningslinjer for ernæringsbehandling i Helse Bergen HF 
 
 
Oppkast: Reduser eller stans næringstilførselen. Undersøk grunn til oppkast, og gjenoppta når den er 
behandlet. 
Diare ved for rask infusjonshastighet og næring gitt i bolus. Vurder Loperamid. Noen har god effekt 
av Biola 100 ml x2/dag etter antibiotikabehandling. 
Kontaminasjon. Sondeløsninger kan henge i opptil 24 timer. Sonden gjennomskylles med  
vann etter avsluttet tilførsel. Tilførselssettet skiftes en gang i døgnet.  
Intoleranse: Alle sondeløsninger er gluten- og klinisk laktosefrie. Spor av laktose kan forekomme i 
løsninger med melkeprotein, men det er svært sjelden at noen reagerer på så små mengder. 
Sondeløsninger tilsatt glutamin kan inneholde spor av gluten, men i så små mengder at cøliakere som 
tåler vanlig glutenfri kost kan få disse.  
Oppblåsthet og følelse av metthet forekommer når pasienten får for mye sondeløsning, når 
sondeløsningen gis i for høyt tempo eller det gis for mye fiber.  Reduser volum, øk tiden det gis på og 




Retningslinjer for ernæringsbehandling i Helse Bergen HF 
 
 
6. Parenteral ernæring 
 
Parenteral ernæring er, med få unntak (17-20), indisert der næringsinntaket per os eller enteralt er 




Perifer venekanyle ved forventet parenteral ernæring < 1 uke med gode perifere vener. Tynn  
kanyle (rosa  1,0 -1,1 mm) legges i en stor vene. Innstikksstedet inspiseres x 1-2/dag,  
veneflonen skiftes minimum hvert 2. døgn og ved tegn til tromboflebitt. Unngå løsninger med  
osmolalitet > 1000 mOsmol/kg. Eksempel: Oliclinomel N4 550 E. 
Sentralvenøst kateter brukes ved forventet parenteral ernæring > 1 uke og der man ønsker å gi mer  
konsentrerte løsninger enn f eks Oliclinomel N4 550 E.  
 
 
2. Parenterale løsninger 
Parenteral ernæring gis oftest som storposer hvor glukose, fett og aminosyrer blandes umiddelbart før 
bruk. På det norske markedet er det tilgjengelig storposer fra ulike firma; Baxter, Braun og Fresenius 




Fettløselige vitaminer: Vitalipid, normalt døgnbehov: 1 hetteglass.  
Vannløselige vitaminer: Soluvit, normalt døgnbehov: 1 hetteglass 
Blanding med både fett- og vannløselige vitaminer: Cernevit, normalt døgnbehov 1 hetteglass.  
NB: Cernevit inneholder ikke vitamin K. 
Vitamin K (Konakion): Vurdér ukentlig tilførsel. 
Sporstoffer: Tracel, normalt døgnbehov: 1 hetteglass. 
 
 
4. Spesielle behov 
Til pasienter med spesielle behov finnes forskjellige løsninger med glukose, aminosyrer og fett.  
Disse benyttes i Sykehusapotekets produksjon av egne ”storposer” tilpasset den enkelte  
pasient. Kfr Metodebok for Intensivmedisinsk seksjon: http://innsiden.helse-bergen.no/enhet/ksk/metode/ 
Eksempler: Ved respirasjonssvikt med CO2 retensjon reduseres mengden karbohydrat. Ved nyresvikt 
gis redusert protein- og elektrolyttmengde, men energirik. Til intensivpasienter: Glutamin gir bedre 
resultat. Ved leversvikt er forgrenede aminosyrer aktuelt. 
 
 
5. Praktisk gjennomføring  
Parenteral ernæring startes når pasienten er stabil. Løsninger bestilles fra Sykehusapoteket på eget  
skjema. Den parenterale ernæringsløsningen skal alltid tilsettes vitaminer og sporstoffer.  
I noen tilfeller vil det være aktuelt å tilsette ekstra elektrolytter. Vær spesielt oppmerksom på økt  




Mangeltilstander på grunn av mangelfull tilførsel av vann- og fettløslige vitaminer og 
sporstoffer. Endring i leverfunksjon med forhøyede transaminaser og bilirubin (stasemønster). 
Hyperosmolaritet. Forhøyede triglyserider. Forhøyet blodsukker. Refeeding syndrom. 
Overfeedingsyndrom. Komplikasjoner til venekateter og kanyle (22).   
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Ernæringsbehandlingen monitoreres kontinuerlig ut fra: 
 1: Mengden som er gitt 
 2: Effekt av behandlingen 
 3: Toleranse 
Vurderingen dokumenteres i journalen.  
 
Vekt: Pasienter innlagt i sykehus bør veies ukentlig, og noen to ganger/uke. 
  
Følg blodprøver. Dette er spesielt viktig når hovedmengden av ernæringen gis intravenøst. 
 
Forslag til blodprøveovervåking: 
 
Parameter X 2/dag X 1/dag X 2/uke X 1/uke X1/md 
Glu, K, fosfat, laktat akutt stabil langtid     
Na, Cl, Ca, Mg, TG, Kreatinin, karbamid   akutt stabil langtid   
INR, ASAT, ALAT, ALP, bilirubin, ammoniakk, 
amylase     akutt langtid   
Total protein, transferrin, prealbumin     akutt stabil langtid 
Sporstoffer         langtid 
Vitaminer         langtid 











Ernæringsbehandling kan foregå i hjemmet etter at pasient er utskrevet fra sykehuset. 
Rikstrygdeverket dekker ernæringsløsningene etter søknad, og Helse Bergen dekker nødvendig 
forbruksmateriell.  
• Lege fyller ut ”Nasjonalt skjema for behandlingshjelpemidler 2004" som lastes ned fra 
www.behandlingshjelpemidler.no  Husk å føre opp diagnose og om det er behov for tilleggsutstyr  
som pumpe, ryggsekk eller stativ. Sykehuset har avtale med Fresenius Kabi på Applix Smart 
ernæringspumpe. Hver pumpe har et registreringsnummer og skal regelmessig kontrolleres og 
valideres av Medisinsk teknisk avdeling (MTA). Pumpene oppbevares hos MTA.   
• Fyll ut skjemaet " Bestilling av forbruksmateriell til hjemmeernæring" som fås fra Seksjon for 
behandlingshjelpemidler, tlf 7-3896.  
• Begge skjemaene sendes til Seksjon for behandlingshjelpemidler via internposten. Seksjon for 
behandlingshjelpemidler holder til i Møllendalsveien 1. 
• Pasienter får med skjemaet "Anskaffelse av utstyr til hjemmeernæring", og ringer selv når han/hun 
trenger påfyll av forbruksmateriell.  
• Lege må skrive resept på sondeløsning eller Oliclinomel, klorhexidin og NaCl.  
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NMS Quadriceps Hangrip BMI3C353BMI3A BMI3B353BMI3A Phase3Angle FM3% FFM3kg LOS BMI3C BMI3B BMI3A Protein3C protein3B Protein3A EI3C EI3B EI3A Age
Age
r = -0.544                 
p = 0.020
r = -0.288                 
p = 0.364
r = -0.720                 
p = 0.008
r = 0.039                 
p = 0.905
r = 0.025                 
p = 0.940
r = -0.275                 
p = 0.442
r = 0.055                 
p = 0.880
r = -0.598                 
p = 0.068
r = 0.618                 
p = 0.008
r = -0.129                 
p = 0.647
r = 0.041                 
p = 0.893
r = -0.286                 
p = 0.265
r = 0.215                 
p = 0.442
r = -0.418                 
p = 0.107
r = -0.805                 
p = 0.000
r = 0.140                 
p = 0.620
r = -0.334                 
p = 0.206
r = -0.621                 
p = 0.008
r = 0.000                 
p = 1.000
EI3A,3kcal
r = 0.111                
p = 0.718
r = 0.286                 
p = 0.535
r = 0.450                 
p = 0.310
r = 0.381                 
p = 0.352
r = 0.133                 
p = 0.681
r = 0.086                 
p = 0.872
r = -0.657                 
p = 0.156
r = 0.143                 
p = 0.787
r = 0.209                 
p = 0.515
r = -0.224                 
p = 0.533
r = -0.209                 
p = 0.494
r = 0.214                 
p = 0.482
r = -0.067                 
p = 0.855
r = 0.409                 
p = 0.116
r = 0.795                 
p = 0.000
r = -0.115                 
p = 0.751
r = 0.585                 
p = 0.017
r = 0.000                 
p = 1.000
EI3B,3kcal
r = 0.222                 
p = 0.488
r = -0.086                 
p = 0.872
r = -0.116                 
p = 0.827
r = 0.262                 
p = 0.531
r = -0.049                 
p = 0.880
r = -0.500                 
p = 0.391
r = 0.000                 
p = 1.000
r = -0.400                 
p = 0.505
r = 0.094                 
p = 0.784
r = -0.517                 
p = 0.154
r = -0.500                 
p = 0.082
r = -0.104                 
p = 0.734
r = -0.333                 
p = 0.381
r = 0.785                 
p = 0.000
r = 0.274                 
p = 0.305
r = -0.200                 
p = 0.606
r = 0.000                 
p = 1.000
EI3C,3kcal
r = 0.178                 
p = 0.525
r = 0.699                 
p = 0.011
r = 0.365                 
p = 0.243
r =-0.385                 
p = 0.217
r = -0.643                 
p = 0.086
r = 0.389                 
p = 0.266
r = -0.515                 
p = 0.128
r = 0.624                 
p = 0.054
r = 0.298                 
p = 0.347
r = 0.007                 
p = 0.980
r = -0.017                 
p = 0.966
r = -0.028                 
p = 0.931
r = 0.900                 
p = 0.000
r = -0.150                 
p = 0.700
r = 0.067                 
p = 0.854
r = 0.000                 
p = 1.000
Protein3A,3g
r = 0.391                 
p = 0.187
r = 0.703                 
p = 0.078
r = 0.818                 
p = 0.024
r = 0.323                 
p = 0.435
r = 0.021                 
p = 0.948
r = 0.290                 
p = 0.577
r = -0.551                 
p = 0.257
r = 0.638                 
p = 0.173
r = -0.187                 
p = 0.560
r = 0.030                 
p = 0.934
r = -0.052                 
p = 0.865
r = 0.187                 
p = 0.541
r = 0.116                 
p = 0.751
r = 0.283                 
p = 0.289
r = 0.000                 
p = 1.000
Protein3B,3g
r = 0.109                 
p = 0.736
r = 0.314                 
p = 0.544
r = 0.174                 
p = 0.742
r = 0.214                 
p = 0.610
r = 0.105                 
p = 0.746
r = -0.800                 
p = 0.104
r = 0.400                 
p = 0.505
r = 0.100                 
p = 0.873
r = 0.192                 
p = 0.571
r = -0.267                 
p = 0.488
r = -0.236                 
p = 0.437
r = 0.038                 
p = 0.901
r = -0.283                 
p = 0.460
r = 0.000                 
p = 1.000
Protein3C,3g
r = 0.145                 
p = 0.607
r = 0.720                 
p = 0.008
r = 0.288                 
p = 0.364
r = 0.028                 
p = 0.931
r = -0.405                 
p = 0.320
r = 0.419                 
p = 0.228
r = -0.442                 
p = 0.200
r = 0.455                 
p = 0.187
r = 0.298                 
p = 0.347
r = 0.018                 
p = 0.950
r = 0.083                 
p = 0.831
r = -0.238                 
p = 0.457
r = 0.000                 
p = 1.000
BMI3A
r = 0.317                 
p = 0.249
r = 0.250                 
p = 0.516
r = 0.317                 
p = 0.406
r = -0.175                 
p = 0.587
r = -0.203                 
p = 0.527
r = 0.679                 
p = 0.094
r = -0.214                 
p = 0.645
r = 0.679                 
p = 0.094
r = -0.156                 
p = 0.628
r = 0.811                 
p = 0.001
r = 0.853                 
p = 0.000
r = 0.000                 
p = 1.000
BMI3B
r = 0.040                 
p = 0.902
r = 0.257                 
p = 0.623
r = 0.232                 
p = 0.658
r = 0.429                 
p = 0.289
r = 0.161                 
p = 0.618
r = 0.600                 
p = 0.285
r = -0.300                 
p = 0.624
r = 0.700                 
p = 0.188
r = -0.280                 
p = 0.466
r = 0.967                 
p = 0.000
r = 0.000                 
p = 1.000
BMI3C
r = 0.219                 
p = 0.433
r = 0.301                 
p = 0.342
r = 0.368                 
p = 0.239
r = 0.266                 
p = 0.404
r = -0.024                 
p = 0.955
r = 0.255                 
p = 0.476
r = 0.103                 
p = 0.777
r = 0.709                 
p = 0.022
r = 0.029                 
p = 0.929
r = 0.000                 
p = 1.000
LOS
r = -0.337                
p = 0.238
r = 0.047                 
p = 0.891
r = -0.359                 
p = 0.278
r = -0.094                 
p = 0.811
r = -0.304                 
p = 0.464
r = -0.321                 
p = 0.400
r = -0.179                 
p = 0.645
r = -0.179                 
p = 0.645
r = 0.000                 
p = 1.000
FFM3kg
r = 0.533                 
p = 0.112
r = 0.770                 
p = 0.009
r = 0.973                 
p = 0.000
r = -0.393                 
p = 0.383
r = -0.400                 
p = 0.600
r = 0.395                 
p = 0.258
r = -0.358                 
p = 0.310
r = 0.000                 
p = 1.000
FM3%
r = 0.345                 
p = 0.329
r = -0.152                 
p = 0.676
r = -0.365                 
p = 0.300
r = -0.071                 
p = 0.879
r = 0.200                 
p = 0.800
r = -0.365                 
p = 0.300
r = 0.000                 
p = 1.000
Phase3Angle
r = 0.230                 
p = 0.523
r = 0.468                 
p = 0.172
r = 0.424                 
p = 0.222
r = -0.714                 
p = 0.071
r = -0.800                 
p = 0.200
r = 0.000                 
p = 1.000
BMI3B353BMI3A
r = -0.103                 
p = 0.763
r = 0.300                 
p = 0.624
r = 0.400                 
p = 0.505
r = 0.857                 
p = 0.007
r = 0.000                 
p = 1.000
BMI3C353BMI3A
r = 0.284                 
p = 0.371
r = -0.050                 
p = 0.898
r = -0.033                 
p = 0.932
r = 0.000                 
p = 1.000
Handgrip,3kg
r = 0.542                 
p = 0.069
r = 0.611                 
p = 0.035
r = 0.000                 
p = 1.000
Quadriceps,3kg
r = 0.633                 
p = 0.027
r = 0.000                 
p = 1.000
NMS
r = 0.000                 
p = 1.000
EI"="energy"intake"
BMI"="body"mass"index"
LOS"="Length"of"(hospital)"stay"
FFM"="Fat"free"mass"
FM="fat"mass"
NMS"="new"mobility"score"
NRS"="nutritional"risk"screening"
All"the"correlation"tests"are"performed"by"Spearmans"Rho."
Any"correlation"is"considered"statistically"significant"if"p"<"0.05.""
Statistically"significant"correlations"are"presented"in"bold.""
"
